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ABSTRACT
Prior to the present study, there was a widespread perception that acute respiratory 
exacerbations result in negative energy balance, which leads to undernutrition in Cystic 
Fibrosis (CF). This study was the first of its kind to characterise the energy balance of 
subjects with CF, through the simultaneous measurement of all the components of energy 
balance in each child; energy intake (Ei); resting metabolic rate (RMR); total energy 
expenditure (TEE) and faecal energy losses (Ei), together with changes in body composition 
during a period of treated acute respiratory exacerbation, and a ‘well’, clinically infection 
free, period. The overall aims of this study were to (i) describe energy balance in a group 
of children and adolescents suffering from CF with a range of respiratory disease during a 
treated acute respiratory exacerbation, and (ii) to determine which component(s) of the 
energy balance equation underwent change during the treated acute respiratory 
exacerbation.
Methods
Fourteen children (6 girls, 8 boys, mean decimal age 9.9 years (SD 2.4) ) were studied when 
‘well’ and during an acute exacerbation treated with intravenous (i.v.) antimicrobial therapy. 
Seven subjects were treated with i.v. antibiotics at the time of experiencing acute respiratory 
exacerbation (‘standard’ i.v. therapy), and seven experienced acute respiratory exacerbation 
but were in the category defined as ‘regular’ i.v. therapy. These seven exhibited more 
severe lung disease and had a history of more frequent acute exacerbations.
A cross over study design was utilised and subjects were studied for 14 days during the 
treated acute respiratory exacerbation, and ‘well’ clinically infection free phase, 
respectively. Body composition was estimated using bioelectrical impedance (BIA) and 
skinfold thickness measurements, pulmonary function was evaluated using standard 
pulmonary function tests, Schwachman score was used to gauge disease severity, and 
growth and nutritional status were determined by means of height, weight and body mass 
index (BMI). Energy and fat intakes were assessed by means of dietary records, using 
household measurements ( 5 - 7  alternate days during the acute exacerbation, and 3 
consecutive days when ‘well’). Resting metabolic rate (RMR) was measured by open-
vi
circuit indirect calorimetry (Datex Instrumentarium, Helsinki, Finland), over a 15 - 20 
minute period after an overnight fast, or 5 hour fasting period. Total energy expenditure 
(TEE) was determined using the doubly labelled water technique over a 14 day period for 
both ‘well’ and exacerbation phases. Faecal fat output was calculated from a three day 
stool collection made during both phases, using a modified method of Van der Kamer et al 
(1949). Changes in faecal fat output were then standardised for fat intake using the co­
efficient of fat absorption (CFA).
The mean paired difference for each energy balance variable between ‘well’ and 
exacerbation phases were calculated for each subject, together with descriptive statistics. 
T-tests and 95% confidence intervals were used to assess the significance of the paired 
differences.
Results
Overall the group were reasonably well nourished (mean BMI SD score -0.31 (SD 0.79); 
mean % body fat 21.8 (SD 5.6) ), and had grown reasonably well (mean height SD score - 
0.54 (SD 1.08) ), considering the fact they had Cystic Fibrosis. The group had managed to 
maintain a reasonably stable nutritional status over the one year period prior to the study 
(mean change in BMI SD score -0.01 (SD 0.61) ). The treated acute respiratory 
exacerbation was associated with a statistically significant, but moderate reduction in energy 
intake (Ej), (mean paired difference 47 kJ/kg/d, p< 0.05). Changes in the other variables 
measured did not reach statistical significance, but the reduction in intake may have been 
offset by a modest decline in overall physical activity. No noticeable effect of acute 
exacerbation on RMR was apparent, and while TEE was lower during the acute 
exacerbation, this change did not reach statistical significance. Furthermore the absence of 
any significant changes in the body weight and composition of the group suggests no 
evidence of marked negative energy balance during the treated respiratory exacerbation.
Vll
Conclusion
Treated acute respiratory exacerbations appear now to represent less of a challenge to 
energy balance in CF than was previously thought. No marked negative energy balance was 
observed during the acute exacerbation. The findings are consistent with very recent 
studies which report that children with CF do not experience negative energy balance during 
acute respiratory exacerbations, irrespective of whether that subject is treated at home (Vic 
et al 1997), or within the hospital setting (Stallings et al 1998). It would appear that for 
certain children with CF, issues surrounding compliance with dietary treatment and 
pancreatic enzyme replacement therapy (PERT) may be regarded as more relevant factors in 
the maintenance of positive energy balance than acute respiratory exacerbation.
To conclude, this study did not support the view that a treated acute respiratory 
exacerbation results in negative energy balance in children with CF. However it is possible 
that an acute exacerbation may be more important to energy balance in older subjects with 
more severe lung disease.
vm
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1.0 Introduction
1.0 General Background
Cystic Fibrosis (CF) is the most common lethal genetic disease affecting those of Caucasian 
descent. It is transmitted as a severe autosomal recessive trait, with an incidence of I 
approximately 1 in 2415 live births, and around 7000 patients have the disease in the United 
Kingdom (Dodge et al 1997).
Cystic Fibrosis (CF) is a multisystem disorder, with chronic pulmonary involvement as the 
major cause of morbidity and mortality. The basic genetic defect in CF causes abnormal ion 
transport regulation in epithelial cells (Rommens et al 1989). Life expectancy has gradually 
improved for patients with CF over the last 50 years, with antibiotic therapy appearing to be 
one of the prime reasons for the improved survival rates. The other main factor which has 
facilitated these improved survival rates, and quality of life is the considerable advances in other 
aspects of medical treatment and the acknowledgement of milder cases, with their inclusion 
within the survival data. Improved prognosis may also be attributed to earlier diagnosis, and 
subsequent early initiation of treatment (Jackson 1989; FitzSimmons 1993).
1.1.0 Genetics And Pathophysiology - The Basic Abnormality In CF
1.1.1 CFTR - The Gene Product
Recent genetic advances have enabled the CF gene itself to be localised to the long arm of 
chromosome 7 (Rommens et al 1989). Though the disease is known to present with various 
clinical manifestations, this genetic disorder is almost certainly the result of a single gene defect 
in the CF transmembrane conductance regulator (CFTR). Genetically, CF has been described 
by some as ‘ Defective CFTR’ (Fiel 1993).
Recent work has shown that the CF gene product, CFTR, (a membrane-bound protein), is 
involved in the regulation of chloride (Cl* ) ion transport across epithelial cells (Kartner et al 
1991). The epithelial linings of the nasal cavity, lower respiratory tract, pancreas.
gastrointestinal tract and the sweat glands are primarily involved (Kerem et al 1990). Research 
suggests that this gene defect, and the accompanying abnormality in ion transport, results in the 
altered composition of epithelial secretions (reduced water content) which cause blocked 
respiratory and pancreatic ducts (Wine 1991; Riordan et al 1989; Alton et al 1992). 
Defective Cl" ion permeability is therefore responsible for the basic physiological abnormalities 
in CF, namely progressive lung disease, pancreatic dysfunction, and elevated sweat electrolytes.
1.1.2 Bàsic Mechanisms Of Respiratory Function
In the healthy respiratory tract, normal mucocilliary clearance is dependant on the upward flow 
of the mucous layer, which lies over the tips of the cilia, which move freely in the fluid (watery) 
layer beneath (Kendigs 1990). Ion transport is governed by absorption of Na^ from the 
mucosal surface, over a favourable gradient, via Na  ^ channels in the cell membrane. Water 
moves osmoticaUy along with the Na .^ A suitable gradient also exists to allow Cl" to leave the 
cell, via Cl channels (Alton et al 1992). This provides a balance between the secretion and 
reabsorption of both water and electrolytes, and prevents any dehydration which may impede 
the upward movement of the mucus layer (Fiel 1993).
In CF airway epithelial cells, Cl" impermeability is present, as identified in CF sweat ducts . The 
current hypothesis is that this fluid contains less water due to the net effect of reduced water 
secretion into the airway, and increased water absorption from it. This is believed to be 
secondary to reduced epithelial cell chloride secretion, and increased sodium absorption 
(Knowles et al 1983; Nelsons Textbook of Paediatrics 1996).
1.1.3 Genotypes And Phenotypes In CF
The first, and most common, mutation described in CFTR is AF508. This represents the 
deletion of an amino acid, phenylalanine at position 508, in the encoded CFTR polypeptide 
(Zielenski & Tsui 1995; Shrimpton et al 1991). In 1994, a world-wide study carried out by 
the CF Genetic Analysis Consortium, screened 43,849 mutant allele-bearing chromosomes in
.
subjects with CF. This survey revealed that the AF508 mutation accounted for 66% of CF 
chromosomes (Kazazian 1994).
In 1991, Shrimpton et al carried out an extensive cohort study, within a predominantly Scottish 
population, to determine the frequency of 16 different mutations of the CFTR gene. It was 
shown that the AF508 mutation had a frequency of 71%, with 51% of CF cases presenting as 
homozygous for AF508. From this study it was also noticed that, in the same Scottish 
population, the G551D mutation was the second most common, with a relative fr-equency of 
6%, with the G542X mutation having a f^requency of 4%. Currently, in excess of 550 
individual mutations of the CFTR gene have been reported, although there is uncertainty as to 
how many different mutations are in existence (Zielenski & Tsui 1995).
Extensive research has been undertaken to try and identify common clinical features among CF 
patients of the same genotype (Zielenski & Tsui 1995; Kerem & Kerem 1996). A more severe 
clinical presentation has been associated with CF patients homozygous for the AF508 mutation, 
(earlier disease onset, higher sweat Cl ' levels, more severe pancreatic insufficiency, and poorer 
nutritional status), compared with those who do not carry the AF508 mutation. However, 
severity of pulmonary disease has been found to vary considerably, even within homozygous 
AF508 patients. Overall, there is still a degree of uncertainty within the area of genotype- 
phenotype correlation, and substantial variation in phenotype is not readily explained by 
genotype (Kerem & Kerem 1996).
From a clinical perspective, CF is characterised by chronic obstructive pulmonary disease and 
bronchopulmonary infection, pancreatic exocrine insufficiency causing malabsorption, and 
elevated sweat electrolytes (namely Na"^ ) (Shepherd & Cleghom 1989; Knowles 1983). Due 
to multiple organ involvement, patients with CF may also display gastrointestinal and hepato­
biliary manifestations at some stage. The extent of this involvement has a major effect on the 
rate of progression of the respiratory disease (Park & Grand 1981). However, discussion here 
is limited to the pancreatic, and respiratory manifestations, because these are of particular 
nutritional significance.
In the CF pancreas, viscous secretions lead to inflammation, fibrosis and blockage of the 
pancreatic ducts. This in turn leads to pancreatic exocrine dysfunction and a reduction in 
delivery of enzymes to the duodenum. This causes fat and protein maldigestion/malabsorption, 
due to a severe deficiency of the digestive enzymes lipase (for the hydrolysis of fat), amylase 
(for the hydrolysis of starch), and trypsin (for the breakdown of proteins to amino acids in the 
duodenum), as well as chymotrypsin, and colipase. The resulting steatorrhoea, (foul smelling 
fatty stools), and the development of nutritional deficiencies, are due to the digestive and 
absorptive processes being greatly impaired (McPherson & Dormer 1992; Francis 1987; 
Sokol 1990). The latter are all common features in untreated CF.
1.2.0 Acute Respiratory Exacerbations
Lung infection is clearly a result of the basic defect in CF, and chronic bronchopulmonary 
infection is regarded as the main cause of advancing pulmonary disease in CF. An acute 
pulmonary exacerbation in the child with CF can be defined as an acute deterioration of 
symptoms and be clinically characterised by: increased cough and sputum production; change in 
sputum appearance; deteriorating lung function and X-ray changes; increased respiratory rate 
(or breathlessness); weight loss and poor appetite; impaired physical activity; rarely pyrexia; 
and treatment with i.v. antibiotics with hospitalisation, at least until recently (Vic et al 1997 ; 
Shepherd et al 1988 ; Dodge 1989; Nelson 1985; Naon et al 1993). The acute exacerbation is 
difficult to define and is known to be more easily recognisable, in terms of physical signs and 
symptoms, to an experienced CF clinician, than definable in a quantitative way. Currently there 
are no single or multiple clinical measures which objectively confirm the presence or absence of 
acute respiratory exacerbation (Rabin et al 1997). It is therefore usually defined as the 
presence of some or all of the clinical symptoms described above, and on the basis that i.v. 
antibiotic therapy is required. Varying combinations of symptoms are possible in any one CF 
child during what could be clinically defined as an ‘acute respiratory exacerbation’ (Rabin et al 
1997). The precise cause of acute respiratory exacerbation is unclear because microbiological 
analysis of sputum samples from patients often indicates similar levels of pathogens, both 
during periods of remission and exacerbation (Nelson 1985).
It has also been suggested that primary Epstein-Barr Virus (EBV) infection may be associated 
with severe respiratory exacerbations, accompanied by a decline in clinical progress for CF 
patients (Winnie & Cowan 1992), and so the microbiology of the acute exacerbation is poorly 
understood.
Treatment of the acute exacerbation in CF involves a standard 14 day course of intravenous 
antibiotics, increasingly home intravenous antibiotic therapy. Administration of the appropriate 
anti-microbial therapy has been shown to improve pulmonary function, and clinical well-being, 
during an acute exacerbation (Smith et al 1988). Treatment is directed at the containment of 
Pseudomonas aeruginosa, (one of the main bacterial pathogens in CF respiratory infection), 
rather than its elimination, since permanent eradication of this pathogen in CF appears to be 
impossible (Szaff etal 1983).
In CF, the acute pulmonary exacerbation is therefore superimposed on the already present, 
chronic infection in the CF lung (Nelsons Textbook of Paediatrics 1996; Forfar & Ameils 
Textbook of Paediatrics 1992). A wide variety of pathogens have been associated with 
pulmonary infection in CF, both bacterial and viral in origin. The main bacterial pathogens, 
affiliated with chronic respiratory infection, in paediatric CF are Pseudomonas aeruginosa. 
Staphylococcus aureus. Pseudomonas cepacia, and Haemophilus influenzae. Historically, 
Staphylococcus aureus was the main bacterial pathogen associated with respiratory infection in 
CF. Initial chronic colonisation of the lungs by this pathogen is particularly damaging, directly 
inducing the process of lung injury in CF. Further colonisation, by Pseudomonas aeruginosa, 
occurs at a later stage (Hoiby 1982) and continues the process of lung injury (Kerem et al 
1990). Pseudomonas eventually colonises the lungs of the majority of patients (Pitt 1986) and 
as the child advances in age, the incidence of this chronic infection is increased.
1.3.0 Clinical Management Of CF
1.3.1 Non-Nutritional Management
Treatment in CF involves a multidisciplinary approach, and compliance with medication, 
nutrition, and physiotherapy are fondamental to control of symptoms in CF Gastroenterology, 
respiratory and dietetic management are all vital to successfully co-ordinated clinical care. 
However, all those therapies are subject to some degree of non-compliance, and are often used 
in circumstances which are difficult. Children with CF, and their families, often have a range of 
medical, social and psychological problems.
Chest physiotherapy continues to be a cornerstone of treatment, along with aggressive 
antibiotic therapy. The standard techniques of percussion and postural drainage assist the 
release of entangled mucus from the lungs (Fiel 1993). For most patients this takes 20-30 
minutes, 2-3 times daily. Physiotherapy is thus very time-consuming, and is therefore subject to 
non-compliance.
Another health professional involved in CF care is the social worker. The social worker must 
provide both patient and family counselling, link in with the clinical team, and child 
psychologist, and be aware of the psychosocial implications of CF, for each individual patient 
and their family (Taub 1990). Due to the multiple social and psychological problems associated 
with having CF, for both the individual as well as the family, the social worker has an important 
role to play in the management of CF.
1.3.2 Nutritional Management
It has long been recognised that children with CF are at a greater risk of developing nutrient 
deficiencies due to maldigestion, malabsorption, and poor energy/nutrient intake (Shepherd et 
al 1980). Deficiencies of both fat soluble vitamins, and essential fatty acids (EFA’s) are 
predominantly due to pancreatic dysfunction (Dowsett 1996). In 1996, Lloyd-Still et al stated 
that deficiency in EFA’s may influence development of respiratory infection with 
Staphylococcus aureus, and Pseudomonas aeruginosa in the child with CF. Children with CF
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typically exhibit poor linear growth and poor weight gain (Wootton et al 1991; Soutter et al.
1986). A decrease in respiratory muscle size is common (Hopkins 1984), as is reduced 
respiratory muscle strength (Arora & Rochester 1982) and each is associated with chronic 
undernutrition. A study carried out by Johannesson et al (1997), found that puberty was 
delayed in female CF patients, (17 females, mean age at peak height velocity 12.9 yrs (SD 0.8), 
and at menarche 14.9 yrs (SD 1.4), in spite of good nutritional, and clinical status. Research 
has demonstrated that enhanced nutritional status may slow the progressive decline in lung 
function in CF (Thomson et al 1995; Levy et al 1985), produce a significant decrease in 
infection rate, promote a steady improvement in lung function (Shepherd et al 1980), and 
improve the strength of respiratory muscles (Wilson et al 1986).
Improved survival rates in CF have been attributed to more effective targeting of nutritional 
management, and thus enhanced nutritional status (Levy a/ 1985; Drury et al 1990). Due to 
maldigestion and malabsorption of both protein and fat, together with the resultant 
steatorrhoea, pancreatic enzyme supplementation (Eg Creon, Pancrease), is an ongoing 
essential part of overall treatment. However, a study carried out by Murphy et al (1991), 
suggested that pancreatic enzymes rarely resolved steatorrhoea completely, and faecal energy 
losses remained approximately 11% of gross energy intake (range 5 - 20%), in the group of 20 
CF children studied, (mean age 11 years). This was compared to a group of 20 normal healthy 
children (mean age 9.0 years) with a mean of 3.5% (range 1 - 6%) of energy intake lost via 
stools.
Children with CF are encouraged to take a diet which provides 120-150% of the recommended 
intake for energy for age (Hubbard 1980; Pencharz et al 1989 ; Daniels et al 1987). However, 
in cross-sectional studies, dietary intake has frequently been reported to fall below such 
recommendations (Ramsey et al 1992; Bell et al 1984; Tomezsko et al 1992; Stark et al 1995; 
MacDonald 1991). Dietary fat (as the most concentrated source of dietary energy) should 
ideally provide approximately 40% of total intake (MacDonald et al 1991; Kawchak et al 
1996).
1.4.0 Energy Balance In CF - Background
It is well known that negative energy balance causes malnutrition in patients with CF (Shepherd 
et al 1991) and that, as indicated previously, malnutrition is commonplace in CF (Chase et al 
1979; Hopkins 1993). The energy demands of a child with CF are believed to be greater than 
those estimated for a child of the same gender, and similar age, typically by about 20 - 50%, as 
noted in the previous section. This is currently believed to be the result of the following 
factors: increased requirements for repair of tissue both during and after bouts of infection; the 
metabolic and imtnunological costs of infection; elevated energy costs of ventilation due to 
chronic pulmonary damage; increased faecal energy losses, due to pancreatic dysfunction 
(Dodge & O’Rawe 1996); and possibly an increase in cellular energy expenditure as a result of 
the defect in ion transport.
It has already been noted that the development of malnutrition and failing pulmonary function 
seem to occur together in CF, (Gurwitz et al 1979; Shepherd et al 1988; Thomson et al 1995; 
Zemel et al 1996) and that respiratory disease, as well as the patients general clinical status, 
may be improved with nutritional intervention (Shepherd et al, 1980; Levy et al 1985; 
Shepherd et al 1986). However, in clinical practice there are a few children who remain well 
nourished in the face of declining lung function. Management is still very much targeted at the 
prevention and treatment of the advancing pulmonary disease, malnutrition and malabsorption.
In CF the aim of nutritional management is therefore to establish a balance between the patients 
energy intake, requirements, and if possible achieve the small positive energy balance required 
for normal growth and development (Shepherd et al 1991; Shepherd & Cleghorn 1989; 
Lloyd-Still et al 1996; Shepherd et al 1984). Zemel et al (1996) found pulmonary function to 
be related to nutritional status in clinically well, mildly diseased CF children, and that 
pulmonary function (FEVi - the volume of air expired in 1 second, one of the main clinical 
markers of pulmonary function) deteriorated in those children who found it dijBScult to mamtain
their percent ideal body weight (% IBW). Percent ideal body weight reflects current body 
weight for actual height.
In a review of CF energy balance literature by Reilly et al (1997) it was noted that the exact 
cause of malnutrition in CF remains uncertain, despite a great deal of research. That is, the 
relative contribution of impaired energy intake, increased energy expenditure, and increased 
faecal energy losses is unknown (Reilly et al 1997). It would therefore appear essential that in 
order to maximise survival and enhance quality of life in CF, the initial priority in nutritional 
research must be to identify the cause(s) of negative energy balance and malnutrition, in order 
to assist in the design of improved nutritional intervention.
1.5.0 Energy Balance In CF
Energy balance can be expressed by the following equation:
AE =  (Ei) - (TEE +  El +  Ed)
where E denotes energy balance, Ei is energy intake, TEE is total energy expenditure, Ei is 
energy losses, and Ed is energy deposited.
The challenge to maintenance of energy balance in CF presents itself as an unknown 
combination of reduced energy intake, elevated energy expenditure (resting metabolic rate, 
RMR and total energy expenditure, TEE), and impaired digestive and absorptive fiinction 
resulting in excessively high energy losses. In order to investigate the problem it is necessary to 
consider all the components of the energy balance equation outlined above. This in turn will 
make it possible to establish the relative contribution of each of these components to the 
development of malnutrition in CF. In other words, which of the components of energy
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balance are clinically significant in CF, to what degree they change as the disease progresses, 
and when they change. Since it is well established that growth and nutritional status become 
more compromised as CF progresses, and more specifically as lung disease itself progresses, 
the components of energy balance must also change progressively in such a way that negative 
energy balance becomes more likely.
1.5.1 Energy Intake In CF
The dietary goal of 120% - 150% of the estimated average requirement (EAR) for energy, in 
CF (Roy et al 1984; Littlewood & MacDonald 1987; Reilly et al 1997), has been perceived 
clinically as appropriate, although no studies have been carried out to verify the suitability of 
this target within CF (Reilly et al 1997). As noted above, evidence exists to suggest that 
children with CF rarely meet the current recommendation for energy intake, (Daniels et al
1987), which constitutes the specific aim in nutritional management of patients with CF. Many 
patients with CF fall short of this target even when clinically infection free, and severe lung 
disease is absent (Kawchak et al 1996; Morrison et al 1994.; Tomezsko et al 1992; Stark et al 
1996; Wootton et al 1991). However, in some studies intakes have been reported to meet the 
CF-specific recommendations, (Salamoni et al 1996; Ramsey et al 1992).
Morrison et al (1994) reported that only nine out of fifty relatively well patients, (median age 
7yrs), achieved > 120% RDA for energy. Energy intakes were determined using a 7 day 
weighed dietary intake method.
In 1991, Wootton et al found that the median Ei of the group of 30 children with CF examined
when well, (median age 8.8yrs), only reached 92% of RDA for energy, even with regular 
dietetic input.
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Tomezsko et al (1992) assessed 22 children with CF, (age 5-lOyrs) who were clinically well, 
had mild lung disease, and who were pancreatic insufihcient. A comparison was made with 23 
healthy controls matched for age, gender and weight. The children with CF in this study had 
higher energy intakes than healthy peers, although energy intakes still fell below the CF 
nutritional recommendations.
Reilly et al (1997) cited that oesophagitis due to acid reflux, anorexia due to the respiratory 
disease itself (psychological suppression of appetite), and shortness of breath (dyspnoea), may 
all contribute somewhat, towards poor Ei. Energy intakes may be further compromised due to 
behaviourally related eating problems in CF. For example. Stark et al (1996) noted that the 
inclusion of an early behavioural intervention strategy within current treatment protocols, has 
been shown to help improve chronically poor eating habits, and nutritional status of children 
with CF. However, a fuller discussion of all these points is beyond the scope of this study (see 
Stark et al 1996; Stark et al 1995).
To summarise these studies, the Ei of children with CF appears not to achieve the current CF 
dietary recommendations, even when children are clinically well, and consuming, in some cases, 
greater quantities of energy than their healthy peers (Stark et al 1995). As well as the 
compromised Ei which occurs outwith periods of acute respiratory exacerbation, consideration 
must also be given to the likelihood of poor Ei during, and after such episodes.
1.5.2 Energy Expenditure In CF
Total energy expenditure (TEE) consists of three components: energy expended on physical 
activity; diet-induced thermogenesis (DIT); basal or resting metabolic rate (RMR). Figure la 
demonstrates each components contribution to TEE as a whole, in typical healthy children. The 
contribution of each of these separate components towards TEE might possibly be different in a 
child with CF, and might change within a child with CF as clinical status changes. Due to RMR
12
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being easily measured, much research in CF has focused on measurement of RMR alone, and 
on the conventional meaning of hypermetabolism (that of increased RMR). Recently, TEE has 
become much more readily measured, due to the introduction of the doubly labelled water 
method (DLW). The measurement of TEE, the sum of all three components, is much more 
informative than simply measuring RMR. True hypermetabolism should be taken to mean an 
increased TEE (Reilly et al 1997). The conventional definition of hypermetabolism can be 
misleading, because in a disease in which RMR is increased, there can be some compensation 
by reduced physical activity, so that TEE is not increased, as in HIV infection, for example 
(MacAllan et al 1995).
Resting metabolic rate has been reported to be increased in patients with CF, relative to 
controls (Tomezsko et al 1994; Zemel et al 1996; Girardet et al 1994; Vaisman et al 1987a; 
Spicher et al 1991; Buchdahl et al 1988). The increase in RMR is typically 10-20% greater 
than predicted values, and patients with CF who have more severe lung disease have 
substantially raised RMR up to 40% above predicted values (Vaisman et al 1987a; Buchdahl et 
al 1988; Steinkamp et al 1989). An important point which has generated a great deal of 
attention to date is that of why RMR is increased in CF. More important, is the question of 
whether raised RMR is relevant in terms of causing increased TEE, and therefore a demand for 
greater energy intake (Reilly et al 1997), but this question has received less attention.
There has been suggestion of a possible link between the main gene mutation in CF and 
elevated RMR (O’Rawe et al 1990; O’Rawe et al 1992), together with a suggestion of an 
associated energy requiring mechanism based at a cellular level (Feigal & Shapiro 1979; 
Shepherd et al 1988). However Durie & Pencharz (1992) made the criticism that such studies 
failed to control for nutritional status or lung function, or adjust RMR for body composition in 
CF patients of different genotype and phenotype. This argument was further supported by 
research carried out in presymptomatic infants with CF (Bronstein et al 1995), and 
asymptomatic children with CF who have mild lung disease (Spicher et al 1991), where no
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difference in RMR was found according to genotype when confounding variables were 
considered. Fried et al {199V) observed similar results in a study of patients with CF who had 
mild to moderate lung disease. Thus, it must be stated that the role of the primary genetic 
defect on hypermetabolism in CF is still unclear, but it probably does not make a major 
contribution to energy imbalance.
There are a number of likely mechanisms which may contribute towards an elevation in RMR in 
CF. It has frequently been postulated that it might arise from the increased work of breathing 
at rest experienced by patients with lung disease (Schols et al 1991; Donahoe et al 1989). 
However, work by Sridhar et al (1994), demonstrated that an elevation in RMR did not parallel 
the increased work of breathing, and that this was unlikely to explain the development of 
malnutrition in lung disease patients alone.
It is now appropriate to briefly consider what other causes may be involved in the increased 
RMR in CF. The relationship between elevated RMR in CF, and deteriorating lung function is 
one which must be given consideration. Fried et al {199V) documented in a study of males with 
CF (aged 7 - 3 9  yrs), that raised RMR strongly correlated with severity of lung disease. 
Resting metabolic rate was shown to rise significantly (125% (SD 14)), in those patients with 
advanced lung disease (FEVi 35% to <70%), when compared to those with milder respiratory 
involvement (FEVi > 75%), who showed smaller increases in RMR Resting metabolic rate 
rose in a curvilinear manner when predicted FEVi fell below 75% (Figure lb). As noted 
earlier, a close relationship exists between changes in pulmonary function (FEVi) over time, 
and nutritional status in CF (Zemel et al 1996). Thus it may be possible to continue good 
nutritional status until such times as more severe lung disease disturbs energy balance (Corey et 
al 1988). However it is currently unclear why lung function should be related to nutritional 
status in CF. One possibility lies in increased RMR, but there is a potential role for elevated 
cytokines, perhaps directly causing deterioration in nutritional status in patients with CF, either
15
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by mediating muscle wasting (as in cancer cachexia), and/or by mediating anorexia (Stuart 
Elborn et al 1993; Reilly et al 1997).
At present, there are only four studies which have described total energy expenditure (TEE) in 
CF, three used the Doubly Labelled Water (DLW) technique (Shepherd et al 1988; Tomezsko 
et al 1994; Bronstein et al 1995), and were carried out in 9 asymptomatic infants with CF who 
have no evidence of chronic lung disease (Shepherd et al 1988), 25 clinically well subjects with 
CF (Tomezsko et al 1994), and 19 presymptomatic infants with CF (Bronstein et al 1995).
Shepherd et al (1988) investigated TEE and its role in disordered energy balance in CF. The 
group with CF, compared with the control data (16 retrospective controls matched for age and 
weight), had a 25% greater TEE. However, it was subsequently suggested by Durie & 
Pencharz (1992), that with further evaluation of more subjects, any differences between the two 
groups vanished. Certain aspects of the methodology used by Shepherd et al (1988) limited the 
results. Firstly, retrospective controls were used from a previous study matched only for age 
and body weight. No match was made for gender, or for body composition, between subjects, 
and controls. Insufficient numbers of subjects with CF were measured, in relation to the 
control numbers. Thus, this study provided no conclusive evidence that TEE was raised in 
asymptomatic infants with CF.
In 1994, Tomezsko et al found that both RMR and TEE were greater in those patients studied 
with CF, than in 25 age, gender and weight matched control children, and that TEE was related 
to CF genotype. Results showed that TEE was 15 - 18% greater than controls, (expressed as 
kcal/kg body weight), but this increase was found to be greater than the 6 - 9 % increase 
accounted for by RMR alone. Higher total energy expenditure (TEE) was only demonstrated 
in subjects who were homozygous for the AF508 deletion. Heterozygous subjects had TEE 
similar to controls (Tomezsko et al 1994). This could be regarded as evidence of 
hypermetabolism in clinically well children with CF. However, the explanation may simply be |
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that the children with CF were able to undertake unlimited physical activity due to the clinically 
well nature of the group. Definitively demonstrating increased TEE is not straightforward, and 
requires more evidence in CF (Reilly et al 1997).
Bronstein et al (1995) found no significant difference in TEE between 19 presymptomatic 
infants with CF, and controls through the use of the DLW technique. Spicher et al (1991), 
found similar results, using heart rate monitoring to estimate TEE, in 13 patients with CF aged 
8 - 2 4  yrs, who were clinically stable. Here the subjects seemed to ‘compensate’ for any 
elevation in RMR by reducing physical activity. A comparison was made with 13 healthy 
subjects, matched for age, gender, height and weight, to provide control data.
In summary, there would appear to be no firm evidence of true hypermetabolism (i.e increased 
TEE) in children with CF at present. However, the studies which have measured total energy 
expenditure in CF concentrated on asymptomatic subjects, or infants and children who were 
clinically well. It is conceivable that TEE might increase during certain periods, such as acute 
exacerbations for example (Reilly et al 1997).
1.5.3 Faecal Energy Losses In CF
The energy content of stools are thought to be derived from 3 main constituents: maldigested 
and malabsorbed dietary residue; endogenous secretions and cellular debris (e.g. 
mucopolysaccharides); colonic bacterial microflora. The relative contribution of each of these 
components varies with dietary intake (Murphy et al\99l).
In CF, steatorrhoea, a condition characterised by stools which contain excess fat, as a result of 
the diminished pancreatic function, provides an indication of the degree of 
malabsorption/maldigestion occurring.
18
Habitual pancreatic replacement therapy is the mainstay of treatment, primarily aimed at 
controlling symptoms. If pancreatic hypofunction remains untreated, as much as 80% of 
dietary energy (in the form of fat), can be lost in stools (Reilly et al 1997). As noted earlier (p 
8), even with regular enzyme therapy, malabsorption may not be completely eradicated 
(Murphy et al 1991). Thus, faecal losses are an important component of energy balance in the 
child with CF.
In 1991, Murphy et al reported that in their group of 20 children with CF (mean age 11.4 yrs), 
who were clinically well and on regular pancreatic replacement therapy, that stool energy losses 
averaged 10.6% (range 4.9 -19.7%) of gross Ei. Stool lipid losses averaged 9.9g/day (SD 0.2) 
in the patients with CF, compared with 2.2g/day (SD 1.2) in healthy controls. However, some 
CF subjects lost up to 20g of lipid/day in the stool (equivalent to approximately 160kcal/day), 
which was approximately three times more than that of healthy children. Gross energy intakes 
of the healthy control group 9460kJ/day (SD 290), and the CF group studied 9930kJ/day (SD 
790), were found to be very similar (Murphy et all99\).
At this point it would seem appropriate to briefly look at the contribution of the other 
components of the energy balance equation. Unfortunately, no evidence is currently available 
on diet induced thermogenesis in CF. However, as Figure la demonstrated, this component 
contributes the least amount to TEE as a whole, and may therefore be of minor significance.
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1.6.0 Energy Balance During Acute Exacerbations In CF
Maintenance of a positive energy balance in CF is widely believed to be seriously challenged 
during acute respiratory exacerbations. The overall effect of these may be cumulative in nature 
(Reilly et al 1997). As age and lung disease advances, and the patient with CF experiences 
more frequent acute respiratory episodes, then these adverse effects may become more
pronounced, causing positive energy balance to be more difficult to achieve/maintain. For the 
child with CF who is younger, has mild disease, good lung fimction and remains in reasonably 
good health, it might be easier to compensate for such challenges, provided energy intake is 
sufficient, and reasonably good growth and nutritional status can be sustained (Durie & 
Pencharz 1992), but the relevant importance of acute exacerbations in younger versus older 
patients is unclear at present.
To date, little attention has been paid to this specific area, and information on each individual 
component of the energy balance equation and its contribution towards energy balance during 
acute exacerbations in CF, is not available. Currently only three studies have been published 
which attempted to examine the effects of acute exacerbations in patients with CF (Naon et al 
1993; Steinkamp et al 1993; Neijens et al 1985). However, these studies considered the effects 
of respiratory exacerbations in a limited way. Two of the studies measured only the effects of 
acute exacerbation on energy intake (Ei), and RMR. Naon et al (1993) recruited 13 patients 
with CF aged 2- 26  years admitted for a mean hospital stay of 15 days; Steinkamp et al (1993) 
recruited 29 patients with CF aged 5 - 2 7  years, who were admitted for 15 days for i.v. anti- 
pseudomonal therapy. Total energy expenditure (TEE) and faecal energy losses were not 
measured in these studies. Neijens and colleagues (1985), concentrated solely on the influence 
of respiratory exacerbation on lung function variables (FEVi - % of predicted) and nutritional 
status (body weight and height) in CF, with no measurement of energy balance components. 
Furthermore, Naon et al (1993), Steinkamp et al (1993) and Neijens et al (1985) studied 
patients with relatively severe lung disease. Naon et al (1993) and Steinkamp et al (1993) also 
carried out measurements during hospitalisation for treatment of an acute exacerbation. In 
modern clinical management of CF, patients are usually treated at home during an acute 
exacerbation. These differences may be of potential relevance to energy balance during an 
acute exacerbation. Neijens and colleagues (1985) failed to state whether the patients with CF 
in the study were measured within the hospital setting, or at home, but it is likely that they were 
treated in hospital.
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Some clinical evidence exists to support the view that weight loss can occur during acute 
exacerbations in CF. A study conducted by Shepherd et al (1988) over a fourteen month 
period, investigated the effects of short-term nutritional supplementation during treatment for 
acute pulmonary exacerbation in CF (15 patients with CF, aged 7 - 1 7  years of age who 
presented with acute respiratory exacerbation). Results suggested that short-term nutritional 
support can reduce the adverse effects of recurrent respiratory exacerbations, and reverse the 
weight loss during these episodes.
During an acute exacerbation, the literature suggests that energy intake is significantly lower 
(Naon et al 1993; Steinkamp et al 1993). Naon et al (1993) speculated that faecal energy 
losses may improve (reduce) during an acute exacerbation - no mechanism was suggested. 
However, Reilly et al (1997) suggested that faecal losses might be elevated during an acute 
exacerbation as a result of impaired colonic salvage of energy secondary to antibiotic therapy. 
There may also be a temporary increase (20% - 30%) in RMR during an acute exacerbation 
(Naon et al 1993; Steinkamp et al 1993; Reilly et al 1997; Fried et al 1991). Having 
summarised the possible effects of an acute exacerbation in CF, it is now appropriate to 
examine the evidence in this area in more detail.
1.6.1 Energy Intake During Acute Respiratory Exacerbation In CF
It has been shown that during and after acute respiratory infections, adult patients typically 
experience negative energy balance, weight loss, and periodic decline in nutritional status, 
mainly caused by inadequate Ei during acute illness (e.g. Klipstein-Grobusch et al 1995). The 
detailed processes that are involved in producing periods of malnutrition/anorexia during bouts 
of infection are, as yet, not fully understood.
As noted above, currently only two studies exist which have investigated energy intake during 
an acute respiratory exacerbation in CF. Steinkamp et al (1993) studied twenty nine patients
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with CF, (19 male, 10 female, aged 5-27 years), with moderate to severe lung disease, who 
were hospitalised for a period of 2 weeks for treatment of acute respiratory exacerbation by 
means of i.v. antipseudomonal therapy. Energy intakes were recorded using 3 day prospective 
weighed dietary records, which were collected during the initial, and final three days of hospital 
stay only. These methods were similar to those employed by Naon et al (1993). Steinkamp et 
al observed a slight increase in daily energy intake towards the end of antipseudomonal 
treatment, (9573kJ (SD 2786kJ) at the start of treatment, rising to 10652kJ (SD 2259kJ) at the 
end of treatment). The slight rise in daily energy intake however did not account for an end of 
treatment mean weight gain of 1.7kg, nor did the changes observed in RMR provide an 
explanation. Within this study no attempt was made to compare daily energy intakes with 
recommended values for age and gender. Therefore, even though energy intake seemed to 
show a rise, no indication was provided of what the data represented in terms of either the 
recommended dietary guidelines for energy intake, or the current CF dietary recommendations. 
There was also no measure of daily energy intake during a period when the patients were 
defined ‘clinically infection free’ (e.g. post hospitalisation), to allow a more objective 
comparison of trends in energy intake to be made between a period of acute exacerbation and a 
‘clinically free of infection’ phase (Steinkamp et al 1993).
In the same year, Naon et al (1993) assessed the energy intake of 13 patients with CF (mean 
age 11 years), by means of two, three day diet diaries (household measures technique). This 
was carried out at the beginning and end of a 15 day hospitalisation period for acute respiratory 
exacerbation. Energy intake was found to increase by 8% from baseline to post treatment (15 
days). However, as with the Steinkamp study (Steinkamp et al 1993), no comparison was 
made with either the recommended energy intakes for age and gender, or the current CF dietary 
recommendations, nor were any energy intake data gathered relating to a period when the child 
was free of an acute respiratory episode. Therefore both these sets of results must be 
interpreted with caution as there are the following doubts about the energy intake data 
presented: there was no indication of the degree of increase in energy intake, and because
reference data were absent, it was difficult to interpret whether the levels of energy intake 
reported were high or low. The limitations of the two existing studies of energy balance during 
acute exacerbation will be discussed in a later Chapter (Section 4.0).
Recently the role of cytokines, and the inflammatory episodes occurring during acute infection, 
have received attention in relation to their role in malnutrition. It has been hypothesised that 
malnutrition, and weight loss in emphysema and chronic obstructive pulmonary disease 
(COPD) for example, may be cytokine mediated (Sridhar et al 1996; Sridhar 1995). These 
studies suggest that acute periods of respiratory illness may result in negative energy balance as 
a result of anorexia, and it is conceivable that this is also true in CF. Tumour necrosis factor - 
a  (TNF - a) is known to function as a mediator in host inflammatory response, and raised 
circulating levels of this have been found to occur in patients with CF during chronic 
Pseudomonal aeruginosa infection (Stuart Elborn et al 1993). TNF - a  levels reduce after anti­
pseudomonal therapy, although levels still remain increased during infection fi*ee periods. 
(Norman et al 1991).
1.6.2 Resting Metabolic Rate During Acute Respiratory Exacerbation In CF
Only two published studies have reported RMR in CF during an acute respiratory exacerbation 
(Naon et al 1993; Steinkamp et al 1993). These two studies reported substantial increases in 
RMR (20-25%) in some, but not all of the patients studied, during the first few days of the 
exacerbation. Naon et al (1993) studied 13 patients (10 female, 3 male; mean age 11 yrs, range 
2 - 2 6  yrs), during a 15 day hospital admission for acute respiratory exacerbation. Resting 
metabolic rate was measured twice over a period of 15 days, until discharge. During this 
period there was a significant reduction in RMR fi-om admission (186 kJ/kg/day (SD 378) ), to 
discharge (141 kJ/kg/day (SD 35) ). Values for RMR, and RMR per kg lean body mass 
showed similar changes during this time. However no comparison was made with any literature 
values, therefore it was difficult to interpret exactly how high RMR was initially, and then
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subsequently what it then fell to in terms of a reference population. Naon and colleagues noted 
that the changes observed in RMR paralleled improvement in the patients clinical status, and 
the amount of change observed was proportionate to the clinical parameters measured (acute 
clinical score, ACS; absolute neutophil count, ANC; respiratory rate, RR & maximal inspiratory 
pressure, MIP). From this it was suggested that acute respiratory infection may be linked with 
a significant rise in the metabolic needs of the patient. No indication was given as to whether 
RMR fell in all the subjects studied, by the end of the treatment period, or the number of 
patients who did not show changes in RMR during the study.
Steinkamp and colleagues (1993) studied 29 patients with CF during acute exacerbation (19 
male, 10 female; aged 5 - 2 7  yrs). During the study eleven of these patients received regular 
prophylactic intravenous antibiotics, and eighteen patients experienced exacerbation of 
respiratory symptoms (increased cough/sputum and loss of appetite). Pre-antipseudomonal 
treatment the mean RMR for the group was 6462kJ/day (SD 1091), (119.0% (SD 14.4) of the 
predicted value) and by the end of therapy RMR had declined to 6218kJ/day (SD 1191), 
(112.8% (SD 11.5) of the predicted value). This represented a significant difference fi'om 
initial values (p<0.05). The initial elevation of RMR was not present in all the patients studied. 
A cut-off point of 115% of predicted RMR was used by the author and, using this, 17 patients 
had raised RMR during the study period, while 12 had a ‘normal RMR’ (comparisons were 
made with the WHO predicted values). Clinical status improved post therapy with significantly 
better values for the clinical parameters measured (acute clinical score, ACS; respiratory rate, 
RR; and vital capacity). Steinkamp et al (1993) also noted that inflammatory indexes such as 
erythrocyte sedimentation rate (ESR), leukocyte count and C-reactive protein were 
significantly related to elevated RMR, and suggested that acute inflammation in lung disease 
may play an important role in determination of metabolic requirements. The elevations in RMR 
for both studies occurred initially prior to the start of antipseudomonal therapy. Resting 
metabolic rate remained high for the first 7- 10 days hospitalisation and therapy, and eventually
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declined towards the end of the hospitalisation period (15 days) (Naon et al 1993 ; Steinkamp 
e / a / 1993).
On the basis of these results Naon et al (1993) and Steinkamp et al (1993) suggested that for 
some patients at least, increased RMR contributed to negative energy balance during acute 
exacerbation.
1,6.3 Total Energy Expenditure During Acute Respiratory Exacerbation In CF
If hypermetabolism was to be a causal factor in the process of malnutrition, and subsequent 
poor growth, then TEE itself must be elevated. It may be the case that TEE may increase (or 
decrease) during episodes of acute exacerbation in CF.
As noted above, it is essential that measurement of this component (TEE) is made if we are to 
begin to understand the relationship between acute exacerbations and energy balance as a 
whole.
In patients with HIV infection, weight loss is episodic, and has a tendency to occur during 
bouts of acute ‘AIDS-defining secondary infection’ (MacAllan et al 1995). This process may 
have relevance for the study of acute exacerbations in CF. In HIV infection, raised RMR 
associated with the primary infection, (Grunfeld 1995; MacAllan et al 1995), was considered 
by some to be the main factor contributing to negative energy balance. More recent research 
has now shown that the episodes of acute infection cause weight loss as a result of anorexia 
(Grunfeld 1995). Poor Ei, and not increased energy expenditure, in HIV infection was the 
principal cause of weight loss during secondary infections (MacAllan et al 1995). MacAllan 
and colleagues (1995) noted that TEE was much lower (not higher) than expected in HTV 
infected patients (in comparison to the values for normal healthy patients). In many diseases 
weight loss might therefore occur when total energy expenditure (TEE) is low, not high. In the
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MacAllan et al (1995) study, subjects who maintained weight had normal total energy 
expenditure (TEE), and energy intake. Reduction in TEE during secondary infection was 
probably due to reduced physical activity, but reduced physical activity did not adequately 
‘compensate’ for reduced energy intake, and negative energy balance occurred in the weight 
losing patient. Evidence also exists to suggest that a decline in physical activity may occur in 
CF (Spicher et al\99\).
A very similar mechanism may conceivably be involved in patients with CF during acute 
respiratory exacerbations. Here, RMR may be significantly raised, with a reduction in physical 
activity. Investigation of TEE during acute respiratory exacerbations in CF would help resolve 
the uncertainty surrounding the question of which component of energy balance changes 
significantly during an acute exacerbation. To date, no studies of TEE during acute 
exacerbations have been reported.
1,6.4 Energy Losses During Acute Respiratory Exacerbation In CF
So far studies of energy losses in the stool in CF have only concentrated on periods when the 
child with CF was well, and research on faecal energy losses during acute respiratory 
exacerbations is lacking. Naon et al (1993) speculated about faecal energy losses being 
reduced during an exacerbation, and Reilly et al (1997) speculated, from reviews of current 
literature, that faecal losses may possibly be elevated.
Colonic bacterial microflora ferment carbohydrate food components which avoid digestion and 
absorption in the small intestine. These processes create short chain fatty acids (SCFA’s). 
Normally SCFA production by this process will yield approximately 7% of daily energy 
(McNeil 1978; Cummings 1981). Due to the malabsorptive processes which take place in the 
CF small intestine, the level of carbohydrate, and fat, supplied to the colon is increased despite 
pancreatic replacement therapy. Under normal circumstances, the bacterial microflora present
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within the colon should be able to recover much of the carbohydrate, and produce energy from 
this. Edwards et al (1986) stated that administration of prophylactic antibiotics, and use of 
large doses for acute infection, may decrease the potential of the microflora to carry out the 
carbohydrate fermentation. In turn this has been shown to cause an increased faecal output in 
healthy adults (Rao et al 1988), and heighten the possibility of diarrhoea linked with increased 
antibiotic usage (Vaisman et al 1992).
To date there have been very few studies which have looked at colonic fermentation in children 
with CF during a period of increased antibiotic usage. One small study by Parrett et al (1996), 
observed the in vitro fermentation capacity of a group of eight CF children, compared with 
eight healthy, age matched controls. Results demonstrated that the children with CF had 
reduced capacity of their colonic bacteria to ferment carbohydrates. Theoretically, a case could 
be put forward to suggest that during a period of acute respiratory exacerbation in CF, when 
increased doses of antibiotics are administered, fermentation capacity is poor, thus causing a 
reduction in the energy available from SCFA’s (Reilly et al 1997).
To conclude the review of current literature on the effects of acute exacerbation on energy 
balance in CF, it would appear that there are still a number of important gaps in present 
knowledge. Research must therefore concentrate on: measurement of total energy expenditure 
(TEE) and faecal energy losses (Ei) (or a suitable proxy for Ei such as faecal fat losses) during 
treated acute respiratory exacerbation in children with CF; measurement of energy intake (E;) 
and TEE in subjects with CF who have more severe lung disease. So far, no research has 
measured the effects of a treated acute pulmonary exacerbation on all the components of 
energy balance, (energy intake, E,; total energy expenditure, TEE; resting metabolic rate RMR, 
and faecal energy losses, E;), simultaneously in the same patient. As noted earlier, much of the 
research on CF has tended to concentrate on children with CF who are clinically infection free, 
with only one or two of the components of energy balance (usually Ei or RMR) being
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investigated, which has provided a very incomplete picture of why negative energy balance 
occurs in CF.
Through the individual measurement of each of the components of energy balance in HIV 
infection, the cause of negative energy balance has been identified (MacAllan et al 1995). In 
view of the favourable results of this approach, these methods can be applied to the study of 
acute exacerbation in CF, to allow understanding of the clinical events which lead to poor 
nutritional status.
The present study was intended to identify and quantify the effects of a treated acute 
exacerbation on energy balance, through investigation of all the components of the energy 
balance equation, and to identify the causes of any negative energy balance observed (i.e. 
changes in intake, expenditure, or losses) during acute respiratory exacerbations. Thus the 
main aims within this study were: (i) to describe energy balance in a group of children with CF 
during a treated acute respiratory exacerbation, and (ii) to measure the effects of a treated 
acute exacerbation on each of the components of the energy balance equation. This was 
carried out through the comparison of a series of measurements made in the same child when 
well and during an acute exacerbation.
As has been shown in CF, and other diseases, malnutrition can result in a number of adverse 
effects, so an enhanced knowledge of what causes negative energy balance in CF could mean 
improved prognosis and quality of life (through the development of specifically targeted clinical 
treatment), for this patient group.
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2.0 Methods
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2.1.0 Cystic Fibrosis Sample Background
The study was conducted at the Royal Hospital for Sick Children (RHSC) in Glasgow, which is 
the largest paediatric centre in Scotland. Children who attend the RHSC for treatment are aged 
0-15 years (Yorkhill NHS Trust Annual Report and Statement of Accounts. 1995 - 1996).
At the time of the study, the Cystic Fibrosis (CF) population for the hospital stood at 110 - 120 
patients. In 1995, the UK had a CF population of 6300, with 587 of these patients resident in 
Scotland. The RHSC is the second largest CF centre in the United Kingdom. The gender 
distribution of the current UK population was 53% male, and 47% female in 1995 (UK CF 
Survey Report 1995).
2.1.1 Socio-Economic Status Of The Sample
Socio-economic status was determined using the Carstairs Scoring System (CSS) for Scotland 
(Carstairs & Morris 1991). This deprivation scoring system is based on the classification of 
postcodes on a scale of 1 - 7, where 1 is the most affluent, and 7 is the most deprived. The 
scale is based upon the values of an unweighted combination of four standardised census 
variables. Those variables are as follows: male unemployment; car ownership; overcrowded 
housing; social class.
This method of assessing the socio-economic status of the sample, was used as it was relevant 
to Scotland, and is currently widely used and accepted in Scotland. The alternative Registrar
Generals 1 - 5  scale uses occupation only as the standard to measure social class, and is now 
regarded by some as being out of date (Carstairs & Morris 1991).
Figure 2a (see page 32), represents the distribution of socio-economic status of the CF sample 
recruited. Although there would appear to be a fairly even spread throughout the categories, 
slightly more of the sample were in deprivation categories 4 -7 (from more deprived areas).
2.1.2 Genotype Of The Sample
The genotype of each subject was obtained from the annual review documents, in the medical 
notes. Recruits were then allocated one of the following genotype categories : AF508 / AF508 
(homozygous for AF508) ; A F508 / Other (heterozygous for AF508) ; Other / Other. The 5 
most common gene mutations occurring in the CF Trust 1995 Survey database are: A F508, 
G551D, G542X, 621 + 1 (G>T), 1898 + 1 (G>A). The incidence of the different CF 
genotypes within Scotland was discussed in the Section 1.0.
2.2.0 Experimental Design
The RHSC CF Team provided a list of suitable patients with CF, who met the requirements for 
participation. Entry criteria were as follows: amenable patients who could cope with the 
experimental protocol; aged 5 - 1 5  yrs; pancreatic insufficient; confirmed diagnosis of CF t
(sweat test). For inclusion as patients experiencing exacerbations, patients had to show 
evidence of increased respiratory symptoms, (e.g. increased cough, increased sputum volume,
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weight loss, wheeze) (Rabin et al 1997) as defined by the attending clinician, and treated using 
i.v. antibiotic therapy as a direct result of these symptoms.
Exclusion criteria were as follows: children under 5 years old; oxygen dependent patients; 
diabetic children; children on Total Parenteral Nutrition (TPN); families with a recent history of 
severe social and/or psychological difficulties.
Letters which detailed:
(i) what the study investigated
(ii) why the study was being carried out
(iii) what specific aspects were being looked at, and why
(iv) what participation would involve for both the child, and his/her family,
were mailed to all prospective recruits, to raise the awareness of the research and facilitate 
recruitment (See Appendix 5.1 & 5.1a). Contact was made with those families at regular clinic 
visits, prior to any recruitment.
Initially, it was decided that only patients with CF admitted to the RHSC for the ‘standard’ 
fourteen day intravenous (i.v) antimicrobial treatment, with a diagnosis of acute pulmonary 
exacerbation and moderate to severe lung disease, would be deemed eligible for inclusion in the 
study. However, over an initial recruitment period of three and a half months, it became 
apparent that insufficient patients with CF were presenting who met the entry criteria. Over a 
recruitment period of three and a half months, 9 routine CF clinics were attended, (136 patients 
in total were seen at those clinics), and fi'om those clinics only two patients were recruited.
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Routine clinics occurred once a week, and patients attended at regular intervals (e.g. once a 
month) according to their well-being, for frequent review. Six weekly emergency CF clinics 
were also attended during this initial period (24 - 30 patients seen at these clinics), and from 
those clinics only one patient was recruited over the same time period. Patients attended the 
emergency clinic if respiratory symptoms showed a deterioration and required medical attention 
immediately, (i.e outwith their routine clinic appointments).
In order to overcome this setback, the study design was altered slightly to also include those 
patients who received regular prophylactic i.v. antimicrobial therapy in order to reduce lung 
disease. Due to the regular nature of clinical treatment, within the latter patient group, 
availability for recruitment was more favourable and predictable. Patients with CF in this 
‘regular’ group were recruited when they presented with increased respiratory symptoms 
requiring antibiotic therapy in advance of their regular clinic appointment for prophylactic 
antimicrobial treatment. In this thesis a distinction is made between these patients (referred to 
as the regular i.v. therapy group), and patients presenting with more ‘classical’ acute 
exacerbations (referred to as the standard i.v. therapy group). Comparisons of respiratory and 
other symptoms between the two groups are provided later in this thesis. In the RHSC CF 
Unit, a fourteen day i.v. antibiotic therapy was standard clinical practice for the treatment of 
acute respiratory exacerbation.
The guardians of suitable subjects were approached at the CF outpatient clinic (Monday 
morning Emergency clinic, or Wednesday morning routine CF clinic) regarding participation. 
Photographs of equipment and measurement techniques were used to provide a full description 
of the protocol. Informed written consent was obtained from each subject’s parents, or
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guardians, prior to beginning measurements. Approval was granted by the Ethics Committee of 
the Royal Hospital for Sick Children, for the study design and protocol.
Subjects were then studied for 12 -14 days, during a time when they could be described as 
clinically stable and infection free (‘well’ phase). It was initially intended that a minimum 
period of one month would be allowed to elapse between completing the exacerbation phase 
and commencing the ‘well’ phase of the plan, to ensure that subjects were clinically stable 
during the ‘well’ phase, and had recovered from the exacerbation. However in subjects 2, 5 
and 13 (symptomatic subjects) a slightly greater period of time elapsed due to those subjects 
being asymptomatic for longer than one month.
However, these criteria had to be flexible, in order to fit in with the patients clinical routine. As 
a result, often more than a month elapsed between phases. In nine out of the sixteen subjects, 
measurements were started during a ‘well’ infection free phase, due to the timing of regular i.v. 
therapy, rather than measuring the child during an exacerbation phase first. Clinical data was 
consulted to monitor each patient’s symptoms, and to guide measurements during both phases 
of the protocol. During the entire 2 x 2  week protocol, it was intended that each subject would 
act as his/her own control, and was expected to undergo the full programme of measurements 
in both phases.
2.3.0 Subjects And Study Protocol
To begin with it was hoped that each patient with CF would be studied, in the hospital setting, 
for a period of 12 - 14 days, during treatment for acute respiratory symptoms. However, since 
the initial design of the study, and the start of data collection, there was a marked trend towards 
home i.v treatment of respiratory exacerbations in patients with CF. In 1995, the total number 
of patients with CF treated by home i.v. therapy at RHSC was 49 (68%), with 23 (32%) being 
treated within the hospital setting (CF Nurses Data, January 1996). However, by the time the 
study began, hospital i.v. therapy was only used for those patients whose families could not 
have coped with home therapy, and the majority of patients were treated using home i.v. 
therapy. The CF Team were responsible for deciding the suitability of a patient, and his/her 
family, for home i.v. treatment. This decision was made after careful consideration of aspects 
such as the social, and psychological circumstances, which pertain to each individual case.
The protocol was then redesigned to (i) accommodate those patients on more regular i.v. 
regimens, so long as they presented with increased respiratory symptoms, and (ii) allow for 
the fact that a large number of patients with CF at the RHSC are now treated by means of 
home i.v. therapy. Therefore, home measurements had to be introduced into the design (See 
Appendix 5.2).
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2.4.0 Techniques
2.4.1 Energy Intakes
i
Energy intake was assessed by means of dietary records, using standard household 
measurements (Gibson, 1990) (See Appendix 5.3) together with supplementary information 
collected by means of a ‘dietary history’ on completion of the food diaries in each phase |  
(MacDonald 1996). Although this method of dietary assessment has been perceived as having 
inaccuracies (the accuracy and precision of this method of dietary assessment will be discussed 
in Section 4.0), it was felt that, in terms of the daily routine of the patients, the intensive nature
■f
of the measurement protocol, and subject compliance, that the methods employed gave as 
accurate and useful a guide to energy intake, as was practical (Sawaya et al 1996).
In 1996, a brief pilot study involving weighed dietary intakes in 4 patients with Acute 
Lymphoblastic Leukaemia, of similar age to the CF sample, revealed under-reporting, thought 
to be attributable in part to non-compliance with the weighing protocol (Ventham & Ralston, 
unpublished data; Livingstone et al 1990; Livingstone et al 1992). In addition, subjects and 
their families who took part in the pilot study reported that the weighing of food presented a 
substantial burden in addition to all the other measurements being made. Thus, as a result, the 
household measures method with dietary recall was used within the CF study, for the reasons 
stated earlier. From a practical view point, it was felt that the practical advantages of the 
method outweighed the disadvantages.
. .  ' ' ' "'''Ci"''
Each subject’s parent was requested to document everything the child ate and drank for a 
period of 5 - 7 days alternately, during the exacerbation phase and 3 consecutive days when in 
the ‘weir phase (including a weekend day). A slightly longer period of recorded food intake 
was employed in the exacerbation phase, as it was anticipated that food intake might vary more, 
as a result of clinical instability (see Section 4.0). To determine whether overall energy intake 
was reduced during the exacerbation period, and for how long this occurred, more frequent 
dietary records were requested (Goldstein et al 1987; Steinkamp et al 1993; Naon et al 1993; 
Chase et al 1979). Parents, and subjects received both verbal and written, comprehensive 
instructions/guidelines for collecting the data. A list of acceptable household measures was 
also provided (See Appendix 5.4).
Emphasis was placed on the child consuming his/her usual diet during the recording periods, 
with normal daily routine, and eating habits to remain unaltered. All foods and beverages were 
estimated in the edible form, and each item then recorded in grams by the parent. A full 
description of all foods taken was documented. Any left-over items were also noted by the 
subject’s parent.
To ensure preservation of normal eating routine, foods consumed outwith the home were 
described as accurately as possible, and quantities estimated as instructed. Regular telephone 
contact was maintained with each subject during this time. Once each subject’s record was 
complete, a detailed verbal dietary recall was carried out to ensure that all the required 
information had been collected and recorded.
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Using the Food Portion Sizes Booklet (MAFF 1994), along with comprehensive, 
supplementary retail data, the weight of each food item, and any left-over food items, was 
determined. The total daily energy and nutrient intakes were calculated using the Comp-Eat 
4.0 software package (Nutrition Systems, London, England), and the food tables by Paul & 
Southgate (1994). This method involved standard corrections for metabolisable energy, and 
this will be discussed further in Section 4.0.
From the analysis of each subject’s food records, the following data were obtained for the 
exacerbation, and the ‘well’ phase, respectively: total mean energy intake (there was no
evidence of systematic changes in Ei over time during either study period (repeated measures 
anova, calculated by Dr J. J. Reilly), thus the mean daily E, was calculated from the 5-7 day 
food record during the acute exacerbation, and the 3 day food record during the ‘well’ phase, 
for each subject respectively, and this figure was then used as a summary measure for the 
energy balance determinations); mean % energy from protein, fat, and carbohydrate; mean 
energy intake in kJ/kg of body weight.
2.4.2 Co-efficient Of Fat Absorption
Standard methods were employed to determine the faecal fat content of CF stool samples, by 
means of Hydroxide Saponification & Petrolieum Ether Extraction (Van der Kamer et al 1949). 
In the study faecal fat output was used as a proxy for faecal energy losses, on the grounds that 
fat contributes most to the energy content of the stool (Murphy et al 1991), and measuring fat 
output was easier (practically) than measuring faecal energy output.
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In order to determine the faecal fat content of the CF faeces, all stools were collected over a 
period of 3 days during the exacerbation, and 3 days during the ‘well’ phase. In certain 
subjects only a 2 day stool collection was possible, due to either non-compliance, or 
disturbance of normal bowel habit (constipation). The stools were collected into polythene 
bags, within commode collection pots, which could be sealed. Parents and subjects were 
provided with full written and verbal instructions to assist the collection.
Each batch of 2 -3 day stools were pooled, and the wet weight obtained (Oxford Series Scales, 
Oxford, England). The lipid content of the 2 - 3 day wet stool sample was determined by 
means of a modification of the method of Van der Kamer et al (1949). Values were noted in 
grams and mmols per day (See Appendix 5.5 for foil modified method). The basic principle 
involved neutral fats (glycerides) being saponified with alkali, to yield glycerol and soaps; fatty 
acids were liberated from the soaps with acid extrapolated, and titrated against standard alkali. 
Values of > 17mmol lipid or 5 g / day are regarded as abnormal, in the CF literature, and by the 
hospital Biochemistry Department.
In order to take account of any alterations which may occur in dietary fat intake, changes in 
faecal fat output were standardised using the coefficient of fat absorption (CFA = (dietary fat 
intake in g - faecal fat in g) / dietary fat intake in g (Tomezsko et al 1992). This was achieved 
through the simultaneous measurement of fat intake firom the dietary records, and the fat output 
from the 2 - 3 day stool collections. A CFA of > 0.93 is regarded as indicating good pancreatic 
enzyme replacement, and can be achieved by CF patients (Ramsey et al 1992).
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2.4.3 Energy Expenditure : Resting Metabolic Rate
Resting metabolic rate (RMR) was determined by open-circuit indirect calorimetry (Deltatrac 
Metabolic Monitor, DATEX Instruments Corporation, Helsinki. Finland). Indirect calorimetry 
was carried out using this piece of equipment, which measured oxygen consumption (VO2), and 
carbon dioxide production (VCO2). From this was calculated (by Haldane transformation 
algorithm) the respiratory quotient (RQ = VCO2 / VO2), and resting metabolic rate (RMR).
To ensure the accuracy of all data, the gas sensors in the Deltatrac were calibrated prior to each 
measurement, using a calibration gas mixture (Datex Instrumentarium Corp., Helsinki. Finland), 
and alcohol burning used periodically as a check on the respiratory quotient.
A clear, perspex ventilated hood was placed over the head and shoulders of the subject, while 
quietly resting. Oxygen consumption and carbon dioxide production were measured in the 
supine position, over a 15 - 20 minute period, after an overnight fast, or 5 hour fasting period, 
for those subjects who would not tolerate an overnight fast. An initial 5 minutes or so was 
allocated to allow for environmental adjustment, or equilibration, by the subject, and were 
eliminated from the calculations. Measurements were taken every minute, until a steady state 
was reached (period of stable minute - minute measurements of RMR), for a minimum of 10-15 
minutes (Steinkamp et al 1993; Naon et al 1993; Fried et al 1991). However, the period over 
which O2 consumption, and CO2 production were measured, differs between many of the papers 
on resting metabolic rate in children (between 5 - 6 0  minutes). For the purpose of our study, 
the expired air collection time for the steady state was 10-15 minutes. This collection period 
was determined according to standard procedures carried out in our laboratory, documented by
41
Reilly et al (1996b) and Ventham & Reilly (1998). These are more practical for children than 
the classical conditions under which RMR has been measured in adults, and the coefficient of 
variation (CV) within subjects is <3% (Ventham & Reilly 1998). Fifteen minutes of steady- 
state sampling was found to be the maximum length of time acceptable to the majority of the 
children, after which a steady-state proved more difficult to maintain, and the quality of results 
decreased (i.e. the coefficient of variation (CV) of minute - minute measurements tended to 
increase). RMR was calculated as the mean of the minute - minute measurements after the 
steady state was achieved. None of the patients were allowed to fall asleep during the 
measurement period, and any gross movements that may have contributed to energy 
expenditure were prevented, by the author.
For each variable measured, mean standard deviation and coefficient of variation (CV) was 
calculated firom the data, and this was used as a guide for data quality. A within measurement 
CV for minute to minute variability in RMR of >8% was deemed unacceptable, and data were 
excluded from the final analysis. The reproducibility of RMR measurement will be discussed 
fully in Section 4.0.
Care was taken to ensure that no routine bronchodilator medications (Pz-agonists) were 
administered during the fasting period, until the procedure was complete. Vaisman et al 
(1987b), found that inhaled Salbutamol, (a selective p2- adrenergic agonist), temporarily 
increased RMR in CF patients fi'om the U.S. A, although the exact mechanism of action (at that 
time), was unknown. Later, Naon et al (1993), stated that Salbutamol was not relevant to 
producing raised RMR, due to the much lower dose currently used in Europe. For the purpose 
of this study, however, it was decided that it was better to avoid use of inhaled Pi-adrenergic
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agonists prior to any RMR measurement. However, in the case of routine i.v antibiotic 
therapy, no specification was made, although if possible the measurement was carried out prior 
to administration of i.v. antibiotic treatment for acute exacerbation. The frequency of 
measurements was different for both phases. Two were carried out during a ‘well’ phase, and 
4 - 6  measurements during the exacerbation. In light of the findings of both the Naon et al 
(1993), and the Steinkamp et al (1993) papers, it was initially thought that during the 
exacerbation, RMR measurements should be carried out on a frequent basis. This was due to 
the instability of RMR observed in some patients during the initial stages of a pulmonary 
exacerbation, found to be present in those two studies (discussed in section 1.6.2). However in 
the present study, after measurements were carried out on 5 - 6 subjects, RMR was not found 
to be as unstable in nature, as was first thought, during the respiratory exacerbation. Thus, the 
frequency of RMR measurements was decreased to approximately 4 - 5 ,  during the 
exacerbation. This point will be considered more fully in Section 4.0. There was no evidence 
of systematic changes in RMR over time during the exacerbation (repeated measures anova, 
calculated by Dr J. J. Reilly), so for each subject the mean RMR for each period was calculated 
and used as a summary measure in the energy balance determinations.
The RMR was measured, rather than basal metabolic rate (BMR), due to the following factors: 
for a BMR measurement, subjects should be measured in the postabsorptive state (no food 
eaten for at least 12 hours before measurements commenced). This was not always practical, 
within this study, and a minimum fast of 4 hours was agreed with the children. For a BMR 
measurement, subjects should be fully rested prior to any measurement (usually 30 minutes rest 
is used in adults), which again is usually not practical in children, especially in a clinical setting.
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2.4.4 Prediction Of Resting Metabolic Rate
RMR for each subject was compared with the two prediction equations from Schofield (1985), 
one used weight (Scho-wt), and the other used weight and height (Scho-wtht). These 
estimates were converted to kJ using : Ikcal = 4.184kJ.
Schofield, weight only (kj/d)
Males 3- lOyrs 22.7 W + 2071
10 - 18 yrs 17.5 W + 2724
Females 3 -10  yrs 22.5 W + 2088
10- 18 yrs 12.2 W + 3121
Schofield, weight & height (kJ/d)
Males 3-lOyrs 19.59W + 130.3H + 1736
10-18yrs 16.25W + 137.2H + 2157
Females 3-lOyrs 16.969W + 161.8H + 1327
10-18yrs 8.365W + 465.0H + 837
Where W -  weight; H = height.
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To ensure clarity of results and presentation, only the Schofield-height weight equation is 
presented throughout this thesis, due to the predicted values derived from both Schofield 
equations proving very similar.
2.4.5 Energy Expenditure: Total Energy Expenditure 
Doubly Labelled Water Technique
Total free-living energy expenditure (TEE), was determined using the doubly labelled water 
technique (DEW - ^H2 ^*0), and was measured over a 14 day period, employing the two-point 
method. Briefly, the technique involved enriching the subject’s body water with isotopes of 
hydrogen (^H), and of oxygen (^*0), and then the wash-out kinetics of each isotope was 
established, as the concentrations fell exponentially towards the levels of natural abundance 
(Schoeller & van Santen 1982). The accuracy of the DLW method has been reported as 1-3%, 
with the precision of the technique between 2-8% in adults. (Schoeller et al 1986; Johnson & 
Halliday 1993; IDECG 1990; Prentice 1995). The doubly labelled water method is widely 
regarded as the only accurate means of measuring the TEE of individual children (Jones et al 
1987; Jones et al 1988; Murgatroyd et al 1993)
Dose Preparation and Dosing Procedure
The dose was calculated from each individual subject’s total body weight (kg). Subjects were 
dosed with 0.06ml/kg ^H2Û (99.8% deuterium), andl.6ml/kg H2 ^*0, body weight (10% ^^ O).
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The reason for this dose ratio was to minimise the effect of changes in background levels of 
and in the body water (IDECG 1990).
Isotopes were delivered to a medical flat (150ml glass bottle: Gallenkamp UK), via a micropore 
filter. Each bottle was shaken, labelled appropriately, and autoclaved to sterilise the dose. The 
dose was then cooled to room temperature, and 2 x 1.5 aliquots were pipetted into bijou pots. 
The bottle was then weighed and refrigerated until required.
Prior to dose administration in each subject, a baseline sample of urine was collected, to enable 
determination of natural isotope abundance levels. Each subject ingested the whole dose using 
a straw, the procedure being abandoned if any dose was spilled. Bottle/dose, straw and bag 
were re-weighed to determine the actual dose consumed (to the nearest 0.01 g).
Each subject was supplied with labelled Universal tubes (x3), inside a resealable plastic box. 
Due to the two-point methodology being used, subjects were requested to collect two ‘spot’ 
urine samples (not the first one of the morning) at the following set times (at least 10ml): one 
day post dose (day 1); two weeks post dose (day 14).
An extra urine sample was also collected at the midpoint (day 7), solely as a back up, however 
this sample was not analysed. Multipoint sampling was impractical, and the analyses would 
have been extremely expensive, thus the two point sampling method was more suitable for use 
in this study. The time of sample collection was documented by the subjects. All urine samples 
were stored in their box, m the freezer until collection by the investigator. The samples were
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then thawed, and sub-divided into duplicate 4ml bijou containers (See Appendix 5.6 for 
description of dose preparation and administration protocol).
Urine isotope enrichments were measured commercially using isotope-ratio mass spectrometry 
(which measures absolute isotope ratios) at the Bureau of Stable Isotope Analysis (BSIA, 
Middlesex, England), following the analytical procedures described by Johnson & Halliday 
(1993).
Doubly Labelled Water Equations
To determine total energy expenditure (TEE), the calculation proposed and validated by 
Schoeller et al (1986; A6), was used. In this study 9 healthy male subjects were dosed, (6 
subjects receiving a low isotopic dose 2.78g ^H^ O 10.28g Hz^ ^O, and 3 subjects a moderate 
dose 5,5g ^H20 13.Og H2^^0) and saliva/urine samples were collected in accordance with the 
two-point method of sample collection. The doubly labelled water method was found to be 
valid when compared with near-continuous respiratory gas exchange, and the two-point 
method of sampling was adequate. The Schoeller equation (A6) provided the best agreement 
with CO2 production rates measured by respiratory gas exchange methods, without any 
reduction in precision, relative to multi-point sampling methods (Welle 1990).
A detailed description of the calculation of TEE is given in Appendix 5.7.
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Physical Activity Level
For each subject. Physical Activity Level (PAL), was calculated as the ratio of total daily 
energy expenditure to the mean measured resting metabolic rate (RMR). This is a description 
of the subject’s usual daily activity (Department of Health 1991).
2.5.0 Body Composition Estimation
2.5.1 Bioelectrical Impedance
Body composition was estimated using the bioelectrical impedance (BIA) method. The 
Bodystat 1500 monitoring unit (50kHz, 800 mAmp, Bodystat Limited, Isle of Man) was used 
to measure bioelectrical impedance in all subjects. This technique is based upon the principle 
that the electrical conductivity of the fat free mass (FFM), is far greater than that of the fat 
mass (FM). The accuracy and precision of bioelectrical impedance has been reported as 
acceptable in adults (Lukaski et al 1986; Lukaski et al 1985; Coward et al 1988), and in 
children (Ventham & Reilly 1998). Azcue et al (1993), stated that in CF BIA can be used to 
achieve a reliable measurement of TBW, as well as FFM.
One major issue which influences the accuracy of estimates of body composition is the 
population specificity of prediction equations. Reilly et al (1996a) concluded from the 
validation study carried out (using underwater weighing as the reference method) in 98 pre­
pubertal children (mean age 9.0 yrs), that the Houtkooper equation (Houtkooper et al 1992)
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for BIA predicted fat free mass (FFM), with the least bias and acceptable accuracy in Scottish 
children. The Houtkooper equation was intended for 10 - 14 year olds, but is valid in younger 
Glaswegian children (Reilly et al 1996a).
Spicher et al (1993), and Borowitz & Conboy (1994), supported the use of BIA in the 
estimation of fat free mass (FFM) in patients with CF. Thirty nine subjects with CF, and 39 
healthy controls, aged 6 - 2 4  yrs were studied. Therefore, the clinical characteristics of CF 
should not rule out the use of the impedance technique.
Body composition was estimated after an overnight fast, or the 4 hour fasting period used for 
RMR measurements. This measurement was carried out in conjunction with the RMR 
measurement, to standardise the technique used. Detailed descriptions of the measurement 
technique are given in Appendix 5.8.
The formulae used to estimate FFM were as follows:
FFM (kg) = 0.61 (RX) + 0.25 (Wt, kg) + 1.31
Where RI = Ht^ (cm^) / Resistance (ohms)
(Houtkooper et al 1992)
FM (kg) = Wt (kg) - FFM (kg)
% BodyFat -  FM (kg) / Wt (kg) x 100
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2,5.2 Skinfold Thickness
Skinfold thickness measurements were made by the one trained investigator (the author), at 2 
sites in female subjects (triceps and subscapular), and 4 sites in male subjects (biceps, triceps, 
sub scapular, and suprailliac). Each measurement was made to the nearest mm, using calibrated 
calipers (Holtain Ltd, Crymych, Dyfed, UK), with the subject in the standing position. In 1995, 
Reilly et al found that the equation chosen to predict body fatness can exert a large effect on
the skinfold estimate obtained (population specificity). Ninety eight, healthy prepubertal
children (64 boys, 34 girls) of mean age 9.1 yrs, were used to test the validity of 5 prediction 
equations, through the comparison of estimates fi'om each of the 5 published prediction 
equations for skinfolds, with measurements of body fatness measured from hydrodensiometry 
(Reilly et al 1995). Within this validation study, the equations of Slaughter et al (1988) for 
girls, and Brook (1971) for boys, were recommended, as they predicted body fatness with 
negligible bias; other published equations were associated with substantial bias.
The Slaughter et al (1988) equation for girls is as follows;
Girls % fat = 1.33 (sum 2 skinfolds; mm) - 0.013 (sum 2 skinfolds  ^; mm) - 2.5
This equation gives body fat directly. However in boys, the Brook (1971) equation works by 
predicting body density. In the boys, body density was therefore estimated in the following 2 
steps :
Predicted density (kg/1) = 1.1690 - 0.0788 x (log sum 4 skinfolds; mm)
5 0
% fat from body density in prepubertal children (Lohman 1989), taking account of lower 
density of FFM in childhood.
Boys % fat = (5.30 / density - 4.89) x 100
The Brook equation (1971) employed all 4 skinfold sites, and the Slaughter equation (Slaughter 
et al 1988) employed measurement of triceps and subscapular skinfolds only.
At the start of the study, CF specific equations for the prediction of body fatness were 
considered. The equations of Johnston et al (1988) were found to underestimate body fatness 
and predicted unrealistically low estimates of body fatness, (e.g. a predicted density of greater 
than 1.1 kg/1, which typically gave rise to estimates less than 0% body fat).
A standard skinfold measurement technique was used (Gibson 1990), and all measurements 
were repeated three times at each site, on the left hand side of the body. However, occasionally 
the right hand side had to be used in subjects, due to the fixed position of the i.v line, (mid 
upper arm) used for administration of antibiotic therapy during treatment of acute respiratory 
exacerbation in CF. The thumb and index finger elevate the skinfold, the calipers were applied 
at the marked point. Further details of these measurements are given in Appendix 5.9.
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2.6.0 Anthropometric Assessment Of Nutritional Status
Anthropometric data were collected from each subject using standard methods (Gibson 1990). 
Height and weight are the two most commonly recorded anthropometric variables. They are 
reasonable indicators of nutritional status and growth (Gordon et al 1991).
Standing height was measured to the nearest 0.1 cm (Gordon et al 1991), using either a 
portable stadiometer (Child Growth Foundation, London), or fixed wall mounted Holtain 
stadiometer in the outpatient clinic. The subject was either barefoot, or wore thin socks. Each 
child was positioned with both feet flat on the base plate, heels together touching the vertical 
board of the stadiometer, or an upright wall, shoulders relaxed, and arms at sides. Care was 
taken to ensure that scapulae, buttocks and the posterior aspect of the cranium were touching 
the vertical board where possible. The head was held so that the subject looked straight 
forward, in the Frankfort plane. The moveable board was brought down to rest on the 
subject’s head, with sufficient pressure to compress the hair. Throughout this procedure, 
constant checks by the investigator were required to ensure a fully erect position was 
maintained. Subjects body weight was measured in kilograms using digital scales, to the 
nearest 0.5kg, (Salter UK, 12kg - 136kg), in the standing position. All subjects wore light 
indoor clothing, and shoes were removed.
Body Mass Index (BMI), weight (kg) / height (m )^, was determined for each subject. BMI 
provides an objective index of ‘protein - energy status’ which adjusts weight for height, and is 
useful for assessing both under and ovemutrition (Gibson 1990)
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Standard deviation (SD) scores were calculated relative to reference data, from the 
measurements obtained for height and weight (Freeman et al 1995), BMI (Cole et al 1995), 
triceps and subscapular skinfolds (Davies et al 1993), in each subject, for both ‘well’ and 
exacerbation phases. The SD score can be applied to individual subject measurements, or to 
group/population data, and is a widely accepted statistic in nutritional assessment (Gibson 
1990).
In all subjects, mid arm circumference (MAC) was measured in the standing position using 
standard methods (Gibson 1990) with arms hanging freely by the sides. The mid-point of the 
upper arm had been marked for the biceps and triceps measurements. The tape (Rabone 
Chesterman, Miniflex 6ft, England), was positioned horizontally around the circumference of 
the mid upper arm, at the marked mid-point. This measurement was employed to provide an 
index of body fatness, and fat free mass (FFM); useful in the clinical setting for assessing 
nutritional status (Gibson 1990)
Mid arm muscle circumference (MAMC) was also employed to describe muscle mass, and 
hence nutritional status. MAMC was derived from the measurements obtained from both 
MAC, and triceps skinfold thickness as follows;
MAMC (mm) = MAC (mm) - (3.14 x TSF mm)
This is a measure of the circumference of the inner circle of muscle mass, around a small central 
core of bone, and provides a more specific index of muscle mass in subjects (Gibson 1990).
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Mid arm circumference (MAC) was also used to provide an indication of body fatness, and fat- 
free mass in subjects.
2.7.0 Clinical Data
2.7.1 Disease Status
For each subject, a range of clinical data were obtained to assist in the determination of overall 
disease severity/status. Standard, CF specific, methods were employed to obtain these data.
2.7.2 Schwachman Score
To gauge disease severity, the scoring system of Schwachman and Kulczycki (1958) was 
applied to each subject. The following four categories were assessed; 1. general activity; 2. 
physical examination; 3. nutritional status, and 4. X-ray findings. Each of these items was 
scored out of 25 points. The assessment and grading was carried out by the attending clinician. 
The status of a patient was regarded as ‘excellent’ if the score was over 85, ‘good’ if the score 
was between 71 and 85, ‘mild’ when between 56 and 70, ‘moderate’ between 41 and 55, and 
‘severe’ when 40, or below (Schwachman and Kulczycki 1958). The Schwachman score was 
used to provide an indication of disease severity (Section 3 .1.0, Table 1).
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During the acute exacerbation it was also possible to collect data pertaining to the lung 
function, general condition, frequency of cough, and sputum volume/colour, of each subject, as 
determined by the attending clinician at examination. This was to form a more objective clinical 
picture, related to whether a subject was experiencing acute respiratory symptoms indicative of 
i.v antibiotic therapy.
2.7.3 Pulmonary Function
Pulmonary function was evaluated at the time of measurement in all patients recruited. 
Standard pulmonary function methods for spirometry, carried out by the RHSC Lung Function 
Laboratory, were used. Measurements included forced vital capacity (FVC), and forced 
expiratory volume in 1 second (FEVi). The latter were performed when each child was 
clinically stable (‘well’) and within the first two days of the acute exacerbation. Data were 
expressed as a percentage of reference values predicted for gender, age and height (Polgar & 
Promadhat 1971). In order to justify recruitment of a subject during an acute respiratory 
exacerbation, FEVi was used as one of the indicators of declining condition and respiratory 
fimction (Section 3.2.0, Table 2) and also of improved lung function during a the ‘well’ phase.
2.7.4 Bacteriology & X-Ray Data
Bacteriology, and x-ray data were also obtained at the time of a measurement period for each 
child. Bacteriology results were consulted at the time of the acute exacerbation to try to 
identify presence of signs indicative of infection; X-ray results were also examined in an attempt 
to determine whether there were any radiological changes consistent with active respiratory
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infection (Section 3,2.0, Table 2 & Appendix 5.10), and similarly to ensure the absence of 
infection to allow ‘well’ measurements to commence.
Additional clinical data may have improved the definition of each measurement phase, but 
unfortunately it was not possible to collect any clinical data for c-reactive protein (CRP), 
leukocyte count, serum albumin concentrations, or a formal objective scoring of symptoms, as 
these data were not routinely collected at the RHSC.
2.8.0 Statistical Analysis
The Minitab (Release 10) statistical analysis package (Minitab Release 10 for Windows, 1994, 
Minitab Inc., U.S.A), was used.
As discussed in Sections 2.2.0 and 2.3.0, it was decided that a paired study design would be 
used, with each subject acting as his/her own control, since both ‘well’ and exacerbation data 
were available in the majority of subjects measured. However, due to a certain degree of non- 
compliance with experimental protocol (collection of faecal samples and urine collections), in 
one of the two study periods, loss of paired data occurred: it was not possible to obtain data 
firom all children for all variables, during both phases. Therefore an unpaired analysis of the 
energy balance data was also carried out. Descriptive statistics (mean and standard deviation) 
are presented.
5 6
The mean paired difference for each energy balance variable between the ‘well’ and 
exacerbation phases were calculated, for each subject. The significance of paired differences 
was assessed using t-tests and 95% confidence intervals. From this it was also possible to 
obtain the p-value (this represents the probability of that result occurring by chance). A 
probability value of less than 0.05 was considered to represent statistical significance. Data 
were presented as kJ/kg/d for clarity of presentation, and comparability across patients of 
different age. As stated earlier (Sections 2.4.1 and 2.4.3) a repeated measures anova was 
carried out on the E; and RMR data (by Dr John. J. Reilly) in order to justify the use of single 
summary measures for those variables in the energy balance determinations.
In one subject (no. 2) the treatment for the acute exacerbation included a prolonged period of 
enteral nutritional support which was not used when the child was ‘well’, and so for energy 
intake, subject no. 2 was excluded from the statistical comparison. All comparisons were 
expressed in the absence of subject 4 during the exacerbation phase because it became clear 
that this subject did not experience acute respiratory symptoms sufficient for inclusion within 
the acute exacerbation category, although a first growth of Pseudomonas aeruginosa was 
apparent, and the patient was treated with i.v. antibiotic therapy as for a typical acute 
exacerbation (Section 3.0).
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3.0 Results
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3.1.0 Clinical And Anthropometric Characteristics Of Subjects
The clinical and anthropometric characteristics of the subjects with CF (mean decimal age 9.9 
years (SD 2.4) ) studied are presented in Table 1. Seven subjects were categorised as 
‘standard’ i.v. therapy, at the time of measurement, and had milder disease as indicated by 
better Schwachman scores (mean score 88 (SD 4) ). Seven were within the category defined as 
‘regular’ (received regular 2-3 monthly i.v prophylactic antibiotics), and had poor< r 
Schwachman scores, (mean score 69 (SD 12) ), which indicated more severe lung disease, bur 
still mild - moderate disease status. Two subjects recruited (subjects 9 & 11) were measured 
when ‘well’ only, due to good health throughout the study period and inability to recruit them 
during an acute exacerbation. These have been included for presentation, but were not 
included in any of the statistical comparisons.
Overall, the group were reasonably well nourished (mean BMI SD score -0.31 (SD 0.79); 
(mean % body fat 21.8 (SD 5.6) ), and had grown reasonably well (mean height SD score -0.54 
(SD 1.08) ), considering the fact they had Cystic Fibrosis. Also presented is the change in BMI 
SD score in the 12 months prior to the study (mean change in BMI SD score -0.01 (SD 0.61) ), 
which showed that the group had managed to maintain a reasonably stable nutritional status, 
over the period of one year prior to the study. It would therefore appear that children with CF, 
and mild to moderate disease, have the ability to maintain adequate growth and nutritional 
status. This will be discussed in greater detail in Section 4.0.
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3.2.0 Clinical Characteristics During Acute Exacerbation
Table 2 shows the clinical assessment of patient’s symptoms, and lung function (% predicted 
FEVi), at the time of acute exacerbation (see Appendix 5.10 for radiology results). The data 
shown in this table were routinely collected as part of each patient’s clinical treatment, and 
were obtained from patient notes. The study did not interfere with any clinical treatment, and it 
must also be stated that any clinical decisions were made completely independently of the study 
itself
The objective data in the table confirm a deterioration in lung function (mean paired difference 
in FEVi 10% (SD 9; p = 0.002)) as a result of the acute exacerbation. The clinical assessments 
were made at the time of intravenous antibiotic therapy, and they confirm a general decline in 
condition, with increased cough frequency and volume of sputum. This was evident in children 
treated with "regular’ i.v. therapy, as well as those defined as receiving "standard’ i.v therapy 
(Table 2). Most of the subjects were treated with i.v antibiotics for the acute exacerbation 
within the home setting (all except numbers 2,4,5,  7, and 13), in contrast to previous research 
which studied subjects in hospital alone.
Subjects 4, 8 and 16 exhibited relatively stable % predicted FEVi values through both 
measurement periods. Subject 4 was treated for a first growth of Pseudomonas during the 
exacerbation phase, and was therefore effectively asymptomatic (i.e was not "unwell’ during the 
exacerbation phase): this accounts for the stable FEVi value. Analysis of all the paired 
differences between study periods was therefore carried out with the omission of subject 4. No
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clinical evidence/explanation can be found as to why FEVi remained unchanged for subjects 8 
and 16. In ‘standard’ i.v subjects (n=7), FEVi declined during the acute exacerbation in 6 of 
the subjects, with one remaining stable (subject 4, as explained above). In the group of 
‘regular’ i.v subjects (n=7), FEVi declined in 4 of the subjects, in 2 subjects FEVi remained 
stable, (8 and 16, as explained above), and in 1 subject FEVi improved during the acute 
exacerbation (subject 5). In the case of subject 5 this apparent improvement in lung function 
during the acute exacerbation might be explained by the fact that she experienced recurrent 
respiratory infection over the 6 month period which followed the exacerbation, during which 
time ‘well’ measurements were attempted, and her poor clinical state may have been reflected 
in the ‘well’ measurements. However, in general clinical assessment (Table 2) tended to 
confirm a worsening of chest symptoms during the exacerbation in both groups, and to confirm 
the clinical impression of a deterioration, characteristic of the acute exacerbation.
The changes in body weight for the group during the 14 day period of the acute exacerbation, 
were small and not statistically significant (mean weight change +0.2kg over 2 weeks (SD 0.7) 
). Subjects were therefore able to maintain their weight relatively well during the acute 
exacerbation. Subject 7 showed a weight gain of +2.0kg during the exacerbation, and this is 
discussed in Section 4.0 of this thesis.
Overall, the data confirm that the subjects studied exhibited evidence of acute deterioration in 
symptoms during the acute respiratory exacerbation, and tend to justify the decision to treat 
them as such clinically.
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3.3.0 Changes In Body Composition And Nutritional Status During Acute
Exacerbation
The changes in nutritional status during the acute respiratory exacerbation are presented in 
Table 3. The data shown in this table were specifically collected for the purposes of the study, 
and are not routinely collected for patients with CF at the RHSC. Data will be presented with 
subject 4 omitted, for the reasons given in Section 2.8.0.
Overall the group managed to maintain reasonably good nutritional status during the acute 
exacerbation, as suggested by the data presented pertaining to body weight during this period. 
The mean paired differences observed for fat free mass (FFM), % body fat and triceps skinfold 
were as follows : FFM (n=13) + 1.2kg SD 2.6 (95% Cl -0.3 to 2.8); % body fat (n=13) -1.1% 
SD 2.2 (95% Cl -2.5 to 0.2); triceps skinfold (n-13) +0.6mm SD 1.8 (95% Cl -0.5 to 1.7). 
These differences were not statistically significant. Only very slight differences were observed 
between day 1 to day 14 of the exacerbation.
In summary, there was no significant change apparent in the nutritional status of the group of 
subjects with CF when measured during the 14 day course of acute exacerbation.
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3.4.0 CF Data Paired By Energy Balance Variable
Subject data paired by energy balance variable are shown in Table 4. Each variable is presented 
for both 'weir and acute exacerbation phases, and is expressed as kJ/kg/day. This format is 
used throughout Section 3.0. The paired difference between the two values is presented, 
together with the group mean data. Subjects 2 and 4 were omitted from paired comparisons 
where appropriate, as explained earlier in Section 2.8.0.
3.4.1 Energy Intake
Energy intake (Ei) (n=ll) fell during the exacerbation period, mean paired difference was 47 
kj/kg/d (SD 49) (95% Cl 14 to 80) p <0.05. In four subjects, energy intake actually increased 
during the acute exacerbation. In one particular subject (subject 2), the increase was marked, 
and this was probably due to the fact that she was hospitalised during the exacerbation: she 
received substantial dietetic input while on the ward and additional enteral feeding (see Section 
2.8.0) which was not given at home (and so was not included in the 'welT measurements).
Unpaired analyses of energy intake differences between the two phases indicated a trend 
towards reduced intakes during the exacerbation, but this did not reach statistical significance 
(p  =  0 .0 9 ).
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3.4.2 Total Energy Expenditure
Paired data for total energy expenditure (XEE) were only available for six subjects. There 
appeared to be a tendency for higher TEE when subjects were ‘well’, with a mean paired 
difference of 15 kJ/kg/d (SD 30); p >0.05. This difference was not statistically significant (95% 
Cl -17 to 46). In two subjects (3 and 4), there was evidence of a higher TEE during the acute 
exacerbation, but in subject 4 this may have reflected the absence of symptoms during the 
‘exacerbation’ as explained earlier.
3.4.3 Resting Metabolic Rate
There appeared to be small and inconsistent differences in resting metabolic rate (RMR), 
(n=12), between ‘well’ and exacerbation phases. The mean paired difference for the 12 
subjects was 0 kJ/kg/d (SD 18). Unpaired analysis of the complete data set, also suggested that 
changes in RMR during the acute exacerbation were small and statistically insignificant. 
Changes observed in RMR during the acute exacerbation were small, and likely to be related to 
measurement variability. The large increases in RMR observed during the acute exacerbation in 
some patients by other authors (Naon et al 1993; Steinkamp et al 1993), were not apparent 
here. Repeated measures anova (carried out by Dr John J. Reilly) on the daily RMR data 
showed no significant differences between days. Two subjects (2 and 6) had RMR values less 
than predicted. Within the present study, measured RMR exceeded predicted RMR by 19% on 
average, which was broadly in accordance with the degree of lung disease in the children 
studied (Fried et al 1991).
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3.4.4 Co-effîcient Of Fat Absorption
Co-efficient of fat absorption (CFA) tended to be lower when subjects were ‘well’. Subject 4 
was omitted from the analyses for reasons previously explained in Section 2.8.0. The mean 
paired difference (n=12) was -0.03 (SD 0.06), which was not statistically significant. The trend 
towards an improvement observed in CFA during the acute exacerbation was probably not of a 
clinically significant nature as the changes were probably too small to have any great effect on 
energy balance in CF.
Subjects 2 and 7 had very low CFA during the ‘well’ phase, and these improved substantially 
during the exacerbation. The latter may be explained by the fact that both subjects were 
suspected non-compliers with pancreatic enzyme prescription. The observed improvement 
during the exacerbation may be attributable to treatment of these subjects within the hospital 
setting during the acute exacerbation, where enzyme supplementation was supervised by 
nursing staff.
Overall the level of fat loss via the faecal route was not high, in comparison with either subjects 
with CF from the literature studied when ‘well’ (20 children with CF mean age 11.4 (SD 1.4), 
mean faecal fat output 9.9 g/d (SD 1.2); Murphy et al 1991), or subjects with CF when studied 
during an acute exacerbation (mean 6.7g/d); Parrett, unpublished data). However, any fat lost 
in CF faeces would be irretrievable energy for such children, thus energy available from dietary 
sources would be reduced.
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3.5.0 Paired Energy Balance Data For Those Children With 
Complete Data For All Energy Balance Variables (n=6).
Table 5 shows the paired energy balance data for the six subjects in whom complete data were 
obtained in all variables during both measurement periods. All data are expressed as means 
(SD) in kj/kg body weight /day. For reasons explained previously (Section 2.8.0), data will be 
described with and without subject 2, as appropriate. Subject 4 was omitted because she was 
asymptomatic during the ‘exacerbation’.
3.5.1 Energy Intake
Energy intake (Ei) showed a decline from ‘well’ to exacerbation phases. If subject 2 was 
omitted the mean paired difference was 46kJ/kg/d (SD 58); p >0.05, Subject 6 demonstrated a 
noticeable fall in Ei during the acute exacerbation phase (31%). Overall the data showed a 
trend towards a fall in Ei during the acute exacerbation (on omission of subject 2), (mean Ei 
‘well’ 320kJ/kg/d (SD 96), mean Ei during the acute exacerbation 274kJ/kg/d (SD 79) ).
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3.5.2 Total Energy Expenditure
Total energy expenditure (TEE) tended to decline during the acute exacerbation (mean paired 
difference 15kJ/kg /d (SD 30); p >0.05). In one subject (3), TEE was slightly higher during the 
acute exacerbation phase.
3.5.3 Resting Metabolic Rate
A small decline was observed in resting metabolic rate (RMR) during the acute exacerbation, 
(3%). The mean paired difference was 5kJ/kg/d (SD 14); p >0.05. These changes were 
probably not clinically significant and did not reach statistical significance. Repeated 
measurement of RMR's during the acute exacerbation produced a between measurement 
coefficient of variation (CV) of 6% within the current study. This was similar to a recent study 
of reproducibility of RMR measurement in prepubertal girls (CV 6%), by Figueroa-Colon et al 
(1996). This will be discussed at greater length in Section 4.0.
3.5.4 Co-efficient Of Fat Absorption
As explained previously, the apparent improvement in CFA observed during the acute 
exacerbation indicated by Table 5 may be explained through better pancreatic enzyme 
compliance during this time in the less compliant subjects. Since subject 2 showed evidence of 
suspected non-compliance with pancreatic enzymes, analyses were carried out with and without 
her: it is clear from table 5 that any improvement in CFA during the exacerbation is due to the 
large change in this subject, and probably reflects the effect of hospitalisation on compliance
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with pancreatic enzyme replacement therapy rather than the effect of the acute exacerbation on 
fat absorption.
3.6.0 Between Group Differences In The Effect Of An Acute 
Exacerbation On Energy Balance
Table 6a, 6b and 6c present a comparison of the subject data for each energy balance variable 
during the ‘well’ and the acute exacerbation phases, divided into subgroups of : ‘regular’ and 
‘standard’ i.v antibiotic therapy; homozygous for AF508 and heterozygous for AF508; boys 
and girls, respectively. This was carried out in an attempt to examine whether the acute 
exacerbation might have had a different effect on energy balance in the different sub-groups 
examined. The data presented within the tables are merely descriptive in nature, and no 
statistical analysis was possible. This was due to the small size of the entire sample, and the 
small numbers which resulted once the group were split into sub-groups. The figures in 
brackets give the percentage change in each variable. Once again, for reasons previously 
explained (Section 2.8.0) data will be described for each subgroup without subjects 2 and 4 as 
appropriate.
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3.6.1 Differences Between Patients In The ‘Regular’ And ‘Standard’ Group
Table 6a shows that the ‘regular’ i.v group exhibited evidence of a decline in energy intake (Ei) 
(6%), and total energy expenditure (TEE) (9%) during the exacerbation, compared with the 
‘well’ results for this subgroup. Resting metabolic rate (RMR), showed a slight increase during 
the exacerbation phase (7%), and CFA remained the same during both phases. As explained 
earlier in this section, this slight rise in RMR may be related simply to the small difference 
observed in repeated RMR measurements in children over a given period of time, and also due 
to the small sample size. Therefore the latter may not be attributable to a real effect of acute 
exacerbation. The ‘standard’ i.v group showed a larger decline in Ei (30%) during the acute 
exacerbation, with TEE showing a fall (13%) during the same period. RMR declined by 4%, 
during exacerbation, with CFA showing an improvement (4% on average).
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3.6.2 Differences In The Effect Of Acute Exacerbation Between Patients Homozygous 
And Heterozygous For ÀF508
The sub-group of homozygous and heterozygous subjects was also examined (Table 6b) to test 
whether the effects of the acute exacerbation might be affected by genotype differences. 
Similar trends could be seen within the homozygous subjects, and heterozygous subjects 
respectively. Overall in homozygous subjects, Ei appeared to decline during the exacerbation, 
(13% on average), TEE declined during the exacerbation, (8%), RMR increased slightly during 
the exacerbation, (3%), and CFA improved during the exacerbation phase (3%). For 
heterozygous subjects the findings were as follows : Ei declined during the exacerbation
(20%), TEE showed a decrease during the exacerbation (11%), RMR and CFA remained static 
from ‘weir to exacerbation phases.
3.6.3 Differences In The Effect Of An Acute Exacerbation Between Boys And Girls
In the girls Ei fell during the exacerbation phase (19%), TEE declined by 6% during the 
exacerbation. RMR fell by 2% during the exacerbation. Co-efficient of fat absorption 
improved during the exacerbation, by 4%. The boys gave the following results : Ei declined 
during a period of exacerbation (15%), TEE declined (13%) during the acute exacerbation, 
RMR showed a slight rise of 4% during the exacerbation, and CFA remained the same during 
this same period.
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In summary, through the examination of differences between the 3 sub-groups, it was apparent 
that the acute exacerbation did not seem to have any marked effect on the energy balance of 
children with CF, which was specific to their gender, genotype or treatment category, (i.e. 
'standard’ or ‘regular’ iv therapy). Throughout the 3 subgroups there appeared to be a very 
similar pattern of events occurring within the four energy balance variables measured, though a 
larger sample would be required to examine the subgroup differences adequately.
3.7.0 Comparison Of Energy Intake Data With Recommendations For CF 
And Other Data
The mean energy intakes (Ei) of the whole CF group, during ‘well’ and exacerbation phases, 
together with the mean data expressed for boys and girls separately, are shown in Table 7. 
Once again subject 4 was excluded fi'om the descriptive analysis, as was subject 2 (Section 
2.8.0). The size of the change in Ei is expressed as a percentage of the literature values and CF 
recommendations presented in Table 7.
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3.7.1 Comparison With DRV’s And CF Specific Recommendations
Overall Ei exceeded the minimum CF recommendation (Wootton et al 1991; MacDonald 1996; 
Green et al 1995) of 120% of EAR (estimated average requirement) for age and gender during 
the ‘welF phase in the ’whole group, and in both boys, and girls. Thus the EAR for energy in 
healthy children was also exceeded (Department of Health 1991).
In contrast Ei fell below the minimum recommended value (120% of EAR), during the acute 
exacerbation for the CF group. However the mean group Ei, as well as the mean Ei for both 
boys and girls, failed to reach the maximum CF recommended target for energy intake of 150% 
of EAR, (Wootton et al 1991; MacDonald 1996), when "welF or during the acute 
exacerbation. When subjects 2 and 4 were excluded from the analysis then the group mean Ei 
when ‘well’ was 344kJ/kg body weight (SD 90), 13% greater than the 120% minimum 
recommended Ei (DRV), and during the acute exacerbation phase, the group mean was 
289kJ/kg body weight (SD 68), 5% less than the minimum EI goal children with CF.
3.7.2 Comparison with Other Relevant Literature Values
A final comparison of the data was made with healthy Glaswegian control children from a study 
carried out in Glasgow of 20 children, (9 boys, 11 girls, mean age 10.7 yrs (SD 2.9yrs) (Reilly 
et al 1998). The same method of household measures was employed in both studies to obtain 
Ei data. During the well phase the group mean, Ei exceeded the corresponding healthy control 
Ei, by 36% for the CF group, 47% for boys, and 15 % for girls, respectively.
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In summary, self reported Ej data from these patients with CF exceeded those from a group of 
similar Glaswegian children studied at the same time with similar methods, as shown above. 
The CF group managed to consume greater than the minimum CF dietary recommendation of 
120% EAR for Ei, when ‘well’ and relatively clinically stable. This must have contributed to 
the relatively good nutritional status of the group noted above. It was also noted that the 
exacerbation made it difficult to achieve an Ei of 120% of EAR.
3.8.0 Comparison Of Measured Resting Metabolic Rate With 
Literature Values
The mean measured RMR values both ‘well’ and during the acute exacerbation for the CF 
group, were shown in Table 8. All mean RMR values are expressed in kJ/kg body weight/day, 
and were compared with the Schofield-height weight (Scho-htwt) prediction equation 
(Schofield 1985). The data were also compared with the Schofield weight only (Scho-wt) 
prediction equation (Schofield 1985). However, as noted earlier the predicted RMR values 
derived from both Schofield equations proved very similar, so to ensure clarity of results and 
presentation only the Schofield-height weight equation is presented throughout (Kaplan et al 
1995). As explained in section 2.8.0, subject 4 has been omitted from any calculation.
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Overall the mean measured RMR values in the CF group during both phases, in both the boys 
and girls, were greater than the predicted values of the Scho-htwt equation. Durie and 
Pencharz (1992) demonstrated that once FEVi dropped below about 75% of predicted values, 
then RMR increased quadratically, thus a link between declining lung fonction and RMR in 
subjects with CF was suggested (Figure lb).
3.9.0 Comparison Of Total Energy Expenditure Data With Literature 
Values
A comparison of mean measured total energy expenditure (TEE), expressed as kJ/kg body 
weight per day, was made with literature values for healthy children taken from a recent review 
by Torun et al (1996), and the 20 healthy Glaswegian control children (described earlier), of 
similar age and gender to the CF group (Reilly et al 1998). Identical methods were used to 
carry out TEE measurements, by the Doubly Labelled Water (DLW) technique, in both groups 
of Glaswegian subjects.
Mean total energy expenditure was slightly higher than the mean value reported by Torun et al 
(1996), (Table 9) during both phases. Mean TEE also exceeded the mean values for healthy 
Glaswegian controls (Reilly et al 1998), for the ‘well’ phase, and matched the value 
(284kJ/kg/day) for the exacerbation phase. Although physical activity levels (PAL) were 
similar to the literature values from Torun et al (1996), they were lower than those of the 
healthy control group. It may be possible that there has been a ‘compensatory’ decline in
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physical activity in the CF patients, and this seems more likely when the increased RMR of the 
patients relative to controls is considered.
3.9.1 Comparison Of Total Energy Expenditure With Other Relevant Literature Values
Finally, a comparison of the TEE data collected when subjects were 'welF was made with the 
findings of Tomezsko et al (1994), who studied 25 prepubertal children with CF using doubly 
labelled water to measure TEE, (13 females and 12 males, mean age 7.7yrs (SD 1.3) ), with no 
evidence of acute pulmonary exacerbation at the time of the study, (or 6 weeks prior to the 
study). In the subjects with CF studied here, mean TEE (‘well’) was lower than that of 
Tomezsko et at (1994), (314kJ/kg/d compared to 351kJ/kg/d), and mean PAL was very similar 
to the group studied by Tomezsko et al (1.65 compared to 1.68).
In summary, average TEE was slightly higher in the group with CF when compared to the 
average literature values (Torun et al 1996), and the mean values for healthy Glaswegian 
control children, but levels of TEE were lower than those reported for a group of children with 
CF studied by Tomezsko et al (1994).
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4.0 Discussion
87
The question of the effect of an acute respiratory exacerbation on energy balance in Cystic 
Fibrosis is an important one. Prior to the present study, there was widespread perception that 
acute exacerbations make a large contribution to undernutrition in CF (e.g. Reilly et al 1997). 
The overall aims of this study were to (i) describe energy balance in a group of children with 
CF who experienced a range of lung disease during a treated acute respiratory exacerbation, 
and (ii) to determine which component(s) of the energy balance equation underwent change 
during the acute respiratory exacerbation. Since the literature failed to provide answers to 
these questions, research must focus on such gaps in current knowledge. Thus, as stated 
earlier, much of the published research presented an incomplete picture of energy balance in 
CF. The study was intended to address the influence of a treated acute respiratory exacerbation 
on energy intake (Ei), resting metabolic rate (RMR), total energy expenditure (TEE), and fat 
absorption in 16 children and adolescents suffering from Cystic Fibrosis with a range of 
respiratory disease. A treated acute respiratory exacerbation was associated with a statistically, 
significant but moderate reduction in energy intake (Ei), but there was no evidence of marked 
negative energy balance. Changes in the other variables measured did not reach statistical 
significance, but the reduction in intake may have been offset by a modest decline in overall 
physical activity. No noticeable effect of the acute exacerbation on resting metabolic rate was 
apparent during the course of the study. From the energy balance and anthropometric data 
presented in this thesis, those children with CF studied not only presented with relatively good 
growth and nutritional status (Sections 3.2.0/3.3.0 Tables 2 & 3), but also managed to maintain 
this, by maintaining energy balance, (Section 3.4.0, Table 4) during the course of the treated 
acute exacerbation.
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Previous studies carried out in hospitalised subjects with acute respiratory exacerbation or chest 
infections in adults, have suggested that a lowered Ei during the exacerbation may produce 
negative energy balance (Naon et al 1993; Steinkamp et al 1993; Shepherd et al 1988; 
Klipstein-Grobusch et al 1995). This, combined with the temporarily increased RMR during 
exacerbation suggested by Naon et al (1993) and Steinkamp et al (1993), has been thought to 
support the view that substantial negative energy balance can occur during such periods of 
acute clinical deterioration in CF (Reilly et al 1997; Fried et al \99V). It has therefore been 
suggested that the cumulative effect of these acute exacerbations (many patients with CF have 
2 -3  acute exacerbations per year) is to produce the undemutrition characteristic of the disease 
(Reilly et al 1997).
However, more recent evidence from this study, and notably from studies carried out by 
Stallings et al (1998), (published in the final preparation of this thesis), Vic et al (1997) and 
Shepherd et al (1988), which found that subjects with CF demonstrated improved weight gain 
and nutritional status following both home i.v. antibiotic therapy, and hospital i.v. antibiotic 
therapy, have suggested that the overall effect of an acute respiratory exacerbation on energy 
balance in children and adolescents with CF is smaller than expected. This small effect on 
energy balance seems to be independent of treatment location (hospital or home). It is apparent 
that in CF the relative contribution of each of the energy balance components to energy balance 
is uncertain (Reilly et al 1997). Thus, as in other chronic diseases characterised by malnutrition 
(e.g. HIV infection) research must focus not only on the periods of decline in clinical well­
being, but also on the measurement of each component involved in overall energy balance, 
simultaneously in each subject. This comprehensive approach, adopted in the present study, is 
necessary for the understanding of exactly what triggers a state of negative energy balance in a
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disease (Reilly et al 1997; MacAllan et al 1995). However, the present study does not support 
the view that acute exacerbations are critical periods of negative energy balance for children 
with CF, at least if the exacerbations are treated.
To date, this is the first study to measure all four components of the energy balance equation 
simultaneously in children and adolescents with CF, and to examine the potential effect of a 
treated acute respiratory exacerbation on each of those components, by comparing 
measurements made during a treated acute exacerbation with those made when the same child 
was ‘well’ and clinically stable. In order to begin identifying the effects of a treated acute 
exacerbation on energy balance in CF it was necessary to adopt a paired study design, i.e. to 
allow each child to be measured during a period of a treated acute respiratory exacerbation and 
again during a period of clinical stability, fi"ee of acute respiratory infection. Each child 
therefore acted as his/her own control. Unfortunately, as the study progressed it became 
apparent that certain of the energy balance variables could not be measured in all children due 
to the following reasons: (i) withdrawal from the study, (ii) poor measurement compliance. It 
was also noted that, even in those more compliant subjects, adherence to the faecal collection 
and urine sampling procedures was not perfect. This ultimately resulted in a loss of paired data. 
Therefore, as a direct result of the incompleteness of the paired data, an unpaired analysis (two 
sample comparison) was carried out. The latter suggested similar conclusions as that of the 
paired analysis (Sections 3.4.0/3.5.0, Tables 4 & 5), i.e. a treated acute exacerbation was 
associated with a trend towards a moderate reduction in Ej, a modest decline in physical 
activity, and no noticeable effect on RMR, or CFA.
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It was also possible to examine the effects of a treated acute exacerbation in the following CF 
subgroups: (i) regular i.v. antibiotic therapy and standard i.v. antibiotic therapy, (ii) genotype, 
i.e. homozygous for AF508 and heterozygous for AF508, (iii) boys and girls; to examine 
whether or not the conclusions may alter any depending on the clinical characteristics of the 
subjects. There were no obvious differences in the effect of an exacerbation noted between 
these clinical groups, and even in those subjects on regular i.v. antibiotic therapy who suffered 
more severe lung disease, and more frequent respiratory exacerbations, no clear differences 
were apparent. However, due to the small sample sizes in these comparisons it was not 
possible to apply any statistical analyses, and there is, of course, a possibility that features such 
as severity of lung disease, genotype, and gender, might influence the effect of a treated acute 
respiratory exacerbation on energy balance. Further studies on larger samples would be 
necessary to test these possibilities. Initially the study aimed at recruiting 12-14 children, with 
paired measurements for each child. The reasoning behind this particular sample size was that 
this was deemed a sufficient number in which to identify a change of 25% in E j, and 20% in 
TEE associated with the exacerbation (Reilly et al 1997). However once the exclusion criteria 
were applied, only eighteen subjects remained eligible for inclusion from the RHSC CF 
population, with only sixteen of those eighteen consenting to participation. The sample size 
may be perceived as small, but the volume and range of energy balance data gathered on each 
subject was greater than in any other comparable study of Cystic Fibrosis to date.
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4.1.0 Energy Balance Variables
4.1.1 Energy Intake
As stated previously in section 2.4.1, it has long been recognised that the accuracy and 
precision of the currently used dietary assessment methodologies are open to much debate and 
criticism (Bingham 1987; Schoeller 1995; Black et al 1993; Sawaya et al 1996; Livingstone et 
al 1990; Livingstone et al 1992). The method of dietary assessment used in this study (Gibson 
1990; MacDonald 1996) may be perceived by some as less accurate than the weighed dietary 
intake method. However recent evidence suggests that weighed dietary intakes are neither 
more accurate or precise than the estimation of energy intake using standard household 
measures, when compared with doubly labelled water measurements of total energy 
expenditure (Sawaya et al 1996). Weighed energy intake data need not exhibit any greater an 
advantage in terms of less error than energy intake records using estimated weights (Bingham 
1987), Each method used to assess dietary intake is subject to its own sources of error within 
different population groups (Bingham 1987). Therefore, it was important to consider what 
degree of error could be tolerated within this study, and to what extent the method chosen 
would impose a burden on the subjects. For this study prospective food intake diaries 
(standard household measures), followed up with retrospective ‘diet history’, were used since 
they would provide a less labour-intensive method of data collection for the subjects. This was 
particularly important in light of the rigorous daily clinical care regimen of the child with CF, 
the intensive measurement requirements of the study protocol (discussed earlier), and the risk 
of non compliance with the protocol. It was felt that the requirement to weigh and record food
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items would have jeopardised compliance with, and participation in the study, with only a 
limited gain in accuracy or precision.
Previously it was reported by Champagne et al (1996) that energy intake recorded by means of 
estimated dietary records have resulted in under-reporting of energy intake in biracial children, 
when verified by the doubly labelled water technique of measuring TEE. The suggestion of 
significant under-reporting of habitual energy intake is also supported by Bandini et al (1990) 
and Livingstone et al (1990), particularly in older children and adolescents. However, Maffeis 
et al (1994) found that non-obese children were reasonably accurate in the recording of 
food/energy intakes by means of 3 day weighed dietary record, and those values were similar to 
TEE estimates obtained. It must also be stated that no gross under-reporting of energy intake 
was obvious in this study: mean energy intakes fell below the 1.3 x measured RMR values used 
to define under-reporting (Goldberg et al 1991; Livingstone et al 1992; Black et al 1997), in 
only two subjects during the ‘welT phase, and three subjects during the exacerbation.
The period of food intake recording was longer during the acute exacerbation than when ‘well’, 
due to the suggestion by previous authors of possible clinical instability during the exacerbation 
leading to increased variability in energy intake (Steinkamp et al 1993; Naon et al 1993), and 
because the greater the number of days recording, the more precise the data obtained (Bingham 
1987). Thus it was proposed that in light of those points there may be a greater opportunity for 
any alterations in habitual energy intake to be observed by increasing the number of days of 
dietary assessment during the acute exacerbation, and the precision of the dietary assessment 
would be maximised. It is also of note that no other comparable study of CF has obtained this 
level of energy intake data. The available energy content of each subject’s diet was calculated
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using a computerised version of the standard food tables of McCance & Widdowson, 
Composition of Foods, 5“' Edition (Comp-Eat 4.0 software package, Nutrition Systems, 
London). No changes in daily E; over the course of the study were noted (repeated measures 
anova, calculated by Dr John J. Reilly), and this justified the use of a single summary measure 
of Ei during each study period.
In this study the mean energy intake of the group during a ‘well’ phase exceeded the minimum 
CF recommendation of 1.2 x estimated average requirement for energy (EAR). A modest fall 
in Ei (16% on average) was observed during a treated acute exacerbation. The value of 1.2 x 
EAR was a more realistic and practical value than the maximum CF recommendation of 1.5 x 
EAR, for this particular group of children (Section 3.7.0 Table 7). In general, the mean 
percentage of energy derived from fat in the diets of those subjects with CF studied was 
between 30 - 35% of dietary intake during ‘well’ and exacerbation phases. This shows that the 
diets of the children studied were not high in fat, and they were within the Dietary Reference 
Values suggested for a healthy daily fat intake, for the general UK population. The children 
within this study appear to have managed to consume an acceptable level of energy intake with 
a dietary fat intake of 30 - 35% during a ‘well’ phase. However, it has been suggested children 
with CF should be encouraged to consume nutritious high calorie foods with moderate to high 
fat contents in conjunction with appropriate pancreatic enzyme replacement therapy (PERT) 
(Ramsey et al 1992; Morrison et al 1994), and so the levels of fat intake observed might be of 
concern.
Overall, a treated acute respiratory exacerbation had a statistically significant but modest effect 
on the energy intake of the CF group studied (mean paired difference 47kJ/kg/d (SD 49);
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Figure 4b). There was an unexpected and sizeable increase in the energy intake of one subject 
(number two) during the acute respiratory exacerbation. In this subject there was known to be 
poor compliance with clinical treatment, and the improved energy intake during this phase was 
attributed to better compliance with the dietetic treatment regimen, and institution of enteral 
feeding in hospital which was not used at home, (treatment during the respiratory exacerbation 
took place within the hospital setting, which differed to the majority of other subjects in the 
study). This supports the exclusion of subject two from the energy intake analyses. Of those 
five subjects receiving nutritional support during an acute exacerbation, the percentage of mean 
energy intake provided by either sip feeds or enteral feeds was variable, but the minimum CF 
recommendation of 1.2 x EAR would not have been reached in the absence of the additional 
nutritional support (Figure 4a).
Poor compliance with the diet prescription in CF might therefore contribute to poor nutritional 
status in some patients at least. Subject numbers 2 & 7 (subject 7 was a suspected non- 
complier with pancreatic enzyme replacement therapy) illustrate that compliance with clinical 
treatment can be essential to the maintenance of energy balance, and thus good nutritional 
status. For these subjects it is possible that the effect of hospitalisation on compliance with 
dietetic regimen and PERT had a greater effect on energy balance that the acute respiratory 
exacerbation itself. This may also support the evidence of the large weight gain observed in 
subject number 7 during his hospitalisation for antibiotic therapy, and it is likely that the oral 
corticosteroid use increased while child number 7 was in hospital (explaining the large weight 
gain during the exacerbation), even though the oral corticosteroid prescription did not change 
during the acute exacerbation.
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Figure 4b 
Energy intake.
Footnote:
Mean paired difference between exacerbation and ‘well’ 
phases was statistically significant (p = <0.05)
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4.1.2 Resting Metabolic Rate
An increased resting metabolic rate (RMR) in subjects with CF has been reported by many 
authors (Steinkamp et al 1993; Naon et al 1993; Reilly et al 1997). It has been hypothesised 
that an elevated RMR may contribute to a malnourished state in CF. One possible mechanism 
for this is the increased energy cost of basic cellular fonctions with the AF508 CF gene 
mutation (Feigal & Shapiro 1979; O’Rawe et al 1990; O’Rawe et al 1992). It has also been 
suggested that an elevated RMR may be closely linked to a deteriorating pulmonary fonction 
(Section 1.5.2; Fried a/ 1991; Vaisman et al 1987a). In the present study RMR was elevated 
relative to predicted values (Schofield Weight Height equation), and those increases were 
broadly consistent with the degree of pulmonary disease (Fried et al 1991; Table 8). Thus an g=■'elevated RMR was present in the subjects with CF, but there appears to be no noticeable ¥
influence of a treated acute respiratory exacerbation on RMR and this was consistent with one 
small previous study (Gamberara et al 1997). In the final preparation of this thesis, it was 
reported by Stallings et al (1998) that in children with CF who have mild to moderate lung 
disease, an acute respiratory exacerbation is not associated with an elevation in RMR. In 
contrast, both Naon et al (1993), and Steinkamp et al (1993) documented that certain subjects 
in their studies exhibited a markedly elevated RMR during an exacerbation. The marked 
instability of RMR in certain subjects during an acute exacerbation (Naon et al 1993; 
Steinkamp et al 1993) was, however, not found in the present study. The RMR measurement 
protocol was from the outset, designed to take account of any short-term variability which had 
been previously reported by both Naon et al (1993) and Steinkamp et al (1993), i.e. sharp 
elevations and declines in RMR during the course of an acute exacerbation, but these were not 
detected (Figure 4c). The conditions under which each individual child’s RMR was measured
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Resting metabolic rate.
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throughout the study period were standardised through the protocol explained in section 2.4.3 
of this thesis, together with the standard procedures used by Reilly et al (1996b) for 
determining the expired air collection period. A minimum of ten to fifteen minutes ‘steady- 
state’ sampling was employed throughout the study to maintain data quality. Measurements of 
RMR were made on 4-5 occasions (alternate days) during the acute exacerbation, and on 2-3 
occasions during the ‘well’ phase. RMR was calculated as the mean of the 4-5 measurements 
during an acute exacerbation, and the mean of the 2-3 measurements during the ‘well’ phase, in 
each subject studied. Repeated measures anova (calculated by Dr John. J. Reilly) on the RMR 
data revealed no evidence of systematic changes over time during the acute exacerbation, or 
‘weir phase, thus the use of a single summary measure of RMR was justified, for both 
measurement phases. Currently there is no obvious explanation for the apparent contradictions: 
observation of elevated RMR during acute exacerbation (in certain subjects) by some authors 
(Naon et al 1993; Steinkamp et al 1993), and no such evidence by the present study and more 
recently other authors (Gamberara et al 1997; Stallings et al 1998). It is possible to speculate 
that one reason for the difference is that Naon et al (1993) and Steinkamp et al (1993) studied 
older CF subjects with more severe lung disease. However, the results of the present study do 
not support this reasoning, as even those subjects with CF who were studied with more severe 
lung disease did not exhibit any obvious instability of RMR, such as ‘spikes’ in RMR, during a 
treated acute respiratory exacerbation. It is also recognised that RMR does not equate to TEE, 
and even if there was an elevation in RMR it does not necessarily imply either an increase in 
TEE, or an alteration in energy balance.
In our laboratory the co-efficient of variation of RMR measurements using our standard 
protocol has been documented at < 3% (Reilly et al 1996b; Ventham & Reilly 1998). The
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standard protocol employed by our laboratory has shown that highly reproducible measurement 
of RMR is possible in prepubertal boys and girls (Ventham & Reilly 1998). Within the present 
study a between measurement co-efficient of variation (CV) of 6% was produced for repeated 
RMR measurements during the treated acute exacerbations. This value was identical to that 
reported by Figueroa-Colon et al (1996) of 6% for measurements of healthy pre-pubertal girls, 
and confirms the reasonably standardised nature of the RMR measurement protocol used 
throughout the study. However, the actual technical repeatability of such measurements during 
an acute exacerbation might be marginally better than is implied by a CV of 6%, due to the lack 
of clinical stability in the CF subjects studied here, which might increase the instability in RMR.
4.1.3 Total Energy Expenditure
It has become evident that the issue of whether or not TEE may be raised in childhood CF 
remains unanswered (Spicher et al 1991; Tomezsko et al 1994; Shepherd et al 1988). The 
subjects within this present study were noted to exhibit a slightly higher TEE when ‘well’ 
(mean paired difference 15kJ/kg/d (SD 30) ). Overall TEE was reduced during an acute 
exacerbation (Figure 4d), but this trend did not reach statistical significance. This probably 
reflected the smaller sample size available for this particular energy balance variable. In order 
for the trend of reduced TEE during a treated acute respiratory exacerbation to have reached 
statistical significance, a much larger sample size of >35 paired comparisons would have been 
required (standardised difference of 0.40, power 0.80, at 5% level - calculated by Dr John J. 
Reilly). This would not have been practical within this group, and currently no other study of 
CF has reached this sample size using the doubly labelled water technique. The absence of any 
marked alterations in body weight/composition in the subjects suggests that the reduction in E;
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Figure 4d
Total energy expenditure.
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must have been offset by a reduced TEE. However this particular variable could not be 
measured in all children with CF recruited due to poor compliance with the DLW protocol, and 
financial limitations on the study. Further research would be required in order to confirm any 
reduction in TEE during an exacerbation.
Overall, the levels of TEE observed in the subjects with CF studied ‘well’ were higher (314 
kJ/kg/d) when compared to the UK Dietary Reference Values for children of the same age and 
gender (Department of Health 1991). Mean TEE was greater during both the acute 
exacerbation and ‘well’ phases, than the average requirements suggested by both Torun et al
(1996), and those of the healthy Glaswegian controls respectively (Section 3.9.0 Table 9). 
However, it would appear unlikely that such levels of TEE observed in the subjects with CF 
within this study would create an energy imbalance. The latter is supported by the fact that the 
children had been nutritionally stable over the previous year (Section 3,1,0 Table 1), Data from 
the present study also suggested that the subjects might have compensated to a certain degree 
for a moderately reduced Ei during the acute respiratory exacerbation through a modest decline 
in energy requirements during the acute exacerbation. This process of ‘compensation’ by 
reduced activity has been demonstrated in other studies of acute illness/disease such as HIV 
infection (MacAllan et al 1995), and it has already been suggested that it is a feature of CF 
(Spicher et al 1991).
To date there have been few studies which have employed the doubly labelled water (DLW) 
method of measuring TEE in children with CF (Shepherd et al 1988; Tomezsko et al 1994), 
However, as previously stated in section 2.4.5 of this thesis, the DLW method of measuring 
TEE (Schoeller & Van Santen 1982; Schoeller et al 1986) is widely regarded as a highly
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accurate means of determining the TEE of children (Jones et al 1987; Jones et al 1988; 
Murgatroyd et al 1993). This particular method has been reported to have an accuracy o f l-  
3%, and a precision of 2-8% in adults (Schoeller et al 1986; Johnson & Halliday 1993; IDECG 
1990; Prentice 1995). The data from the present study could therefore be used in the future to 
aid the assessment of energy requirements in patients with CF.
4.1.4 Co-Efficient Of Fat Absorption
As stated earlier in this thesis, CF is a disease which is characterised by the malabsorption of 
fat, protein and carbohydrate due to pancreatic hypofunction, leading to a reduction in the 
availability of dietary energy (Murphy et al 199 \). Despite regular, optimal doses of pancreatic 
enzyme supplements, the digestion of fat remains sub-optimal in these patients (Stead et al 
1987; Reilly et al 1997). Furthermore, it has been previously reported that elevated stool lipid 
losses may contribute towards poor growth and nutritional status (Murphy et al 1991). The 
effect of an acute respiratory exacerbation on fat absorption was unknown, but had to be 
measured in view of its importance to energy balance in CF.
The present study did not support the view that fat absorption changed during the acute 
exacerbations: mean paired difference in CFA -0.03 (SD 0.06), which did not reach statistical 
significance (Section 3.4.4 Table 4). Subjects 2 & 7 showed distinct improvements in CFA 
during the acute respiratory exacerbation (Figure 4e). This may have been due to an 
incomplete 3 day faecal collection, or a disturbance of normal bowel habit (constipation). 
However, those subjects had also been suspected poor compilers with pancreatic replacement 
therapy (PERT), prior to commencing the study. Both subjects, in contrast to the other
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Figure 4e
Coefficient of fat absorption.
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subjects in the study, had been hospitalised for a considerable part of their antibiotic treatment, 
and would have received a greater level of supervision in terms of their PERT during the acute 
exacerbation. The improvement observed in CFA in subjects 2 & 7 would therefore support 
the view that this change reflected improved compliance with therapy, and not the effect of 
acute exacerbation per se.
The levels of faecal fat lost were generally low in comparison to both subjects with CF studied 
when ‘weir (Murphy et al 1991), or subjects with CF studied during an acute respiratory 
exacerbation (Parrett, unpublished data). When expressed as a % of dietary fat ingested, the 
level of fat/energy lost via the faecal route was not high in the subjects studied. Again, this may 
have been attributable to those same factors stated earlier in this section: incomplete faecal 
collection, constipation or improved PERT compliance. Compliance with these collections was 
not ideal, and the use of radio-opaque markers may have ensured complete collections 
(Morrison et al 1994). Most of the values of CFA exceeded 0.93 which is indicative of 
relatively normal fat absorption, which is not uncommon in CF (Ramsey et al 1992). 
Practically, faecal fat output was used as a proxy measure of faecal energy output within this 
study, as faecal fat output was considered a more straightforward measurement within this 
study protocol than measuring faecal energy output. Access to an automatic adiabatic bomb 
calorimeter (Gallenkamp) for the determination of faecal energy losses was limited.
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4.2.0 Conclusion
The study set out to test whether a treated acute respiratory exacerbation represented a serious 
challenge to the maintenance of positive energy balance in children with CF, through the 
simultaneous measurement of all components of the energy balance equation in each child: Ei; 
RMR; TEE; Ei, together with changes in body weight and composition during a period of 
treated acute respiratory exacerbation and a period when the subjects were ‘well’. The study 
was the first of its kind to characterise the energy balance of subjects with CF by measuring all 
components of energy balance in such detail. Treated acute respiratory exacerbations appear 
now to represent less of a challenge to energy balance in CF than was previously thought. 
From the data presented in this study it has become obvious that the main effect of an acute 
exacerbation in the subjects with CF studied is on the child’s Ei during this period, (this may 
also have applied to a short period of time prior to them being recruited to the study). Overall 
this study has shown that during the period of the treated acute respiratory exacerbation, E; falls 
significantly, changes in RMR and fat malabsorption/faecal fat losses were negligible, and TEE 
might decline. Changes in TEE did not reach statistical significance, but due to minimal 
changes in the body weight and composition (Sections 3.1.0/3.2.0 Tables 1 & 2), as well as the 
minimal changes observed in energy balance during the acute exacerbation, it seems likely that 
TEE fell. The findings are consistent with very recent studies which report that children with 
CF do not experience negative energy balance during acute respiratory exacerbations, this being 
irrespective of whether subjects are treated at home (Vic et al 1997), or within the hospital 
setting (Stallings et al 199%). In summary, the effects on energy balance of a treated acute 
respiratory exacerbation in CF are probably quite small, and it would appear that for certain 
subjects with CF, issues surrounding compliance with dietary treatment and PERT may be
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regarded as far more relevant factors in the maintenance of adequate nutritional status, and 
positive energy balance.
In conclusion, this study did not support the view that a treated acute respiratory exacerbation 
results in marked negative energy balance in children with CF. It is however possible that the 
acute exacerbation might be more important to energy balance in older patients, with more 
severe lung disease, or to the rare occasions when patients present with unusually severe 
exacerbations (requiring intensive care).
4.2.1 The Future For CF Dietetic Management And Research
In this study we have demonstrated that the CF recommendation of 1.2 x EAR can be reached 
by the majority of those subjects studied when ‘well’ and clinically infection free, contrary to 
other studies (Tomezsko et al 1992; Kawchak et al 1996; Anthony et al 1998), and that the 
overall effect of a treated acute exacerbation on energy balance is smaller than was initially 
perceived. This study has also highlighted the importance of compliance with nutritional 
therapy (dietary prescription and pancreatic enzyme replacement therapy) to the maintenance of 
both nutritional status, and energy balance in some patients. However it remains important to 
recognise that, in terms of CF dietetic management, regular nutritional monitoring is still 
imperative before, during and after an acute respiratory exacerbation, and during puberty, as all 
children with CF and the acute exacerbations experienced are individual and unique.
Further studies are required to assess possible changes in energy balance, and nutritional status 
during treated acute respiratory exacerbations in larger numbers of subjects with CF (possibly a
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multi-centre study to ensure an adequate sample size), with more severe respiratory disease and 
over significantly longer time-scales . Future research should also focus on when and why 
negative energy balance occurs in children with CF through the application of similar study 
techniques to the ones used in this study, perhaps using a longditudinal study design with the 
same child followed over longer periods than was possible here.
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APPENDIX 5.1.
Pre-Recruitment Information
Below are samples of the letter mailed, and the information provided, to all prospective 
recruits, detailing the studies broad aims and requirements.
Date as postmark
«Title» «FAMILYNAME»
«Address 1»
«Address2»
«City»
«PostalCode»
Dear «Title» «FAMILYNAME»
CYSTIC FIBROSIS STUDY
(Judith Ralston; Dr John J Reilly; Dr J Paton; Dr J Evans; Dr J Wilkinson)
The Department of Human Nutrition are presently carrying out a study investigating food 
intakes, and weight loss, during chest infections, in children suffering from Cystic Fibrosis.
Through these investigations it is hoped to:
(i) discover the main reason(s) for any fall in body weight during chest infections, and
(ii) how/when the childs weight begins to improve after such an infection.
The findings will help build a more complete picture as to how we can then achieve better 
nutritional management long-term, and also help improve body weight, nutrition, strength and 
growth in children with CF.
PLAN
We hope to collect information on 12 -14 CF patients (during periods of chest infection 
only), aged 6-14  yrs, between November 1995, and March 1997.
Each child will be followed/measured for one month - through his/her hospital stay, home TV. 
treatment ( ie. during chest infection), and 'recovery' from the chest infection at home.
This will allow us to identify any changes which may occur in;
(i) the amount of food eaten by the child
(ii) the amount of calories (energy), used up by the child, and
(iii) their body weight
*** THIS STUDY WILL NOT INTERFERE IN ANY WAY 
WITH YOUR CHILD’S TIME IN SCHOOL ***
132
HOW YOU CAN HELP
It would involve your child taking part in a series of simple measurements, which will be carried 
out by the investigator.
Two of those measurements will require the co-operation/participation of your child and 
yourself. For these, you will be given full guidance, and support.
Your sincerely
Judith M Ralston
IF YOU REQUIRE ANY FURTHER INFORMATION PLEASE 
CONTACT : JUDITH RALSTON
DEPT. OF HUMAN NUTRITION 
YORKHILL HOSPITAL 
GLASGOW 
0141 201 0712
133
APPENDIX 5.1a
Cystic Fibrosis Study Parent Information
The Department of Human Nutrition is presently carrying out a study investigating food 
intakes, and weight loss, during chest infections, in children suffering from Cystic Fibrosis. 
Through these investigations it is hoped to;
(I) discover the main reason(s) for this fall in body weight during chest infections, and 
(ii) how/when the childs weight begins to improve after such an infection.
The findings will help build a more complete picture as to how we can then achieve better 
nutritional management long-term, and also help improve body weight, nutrition, strength, and 
growth in children with CF.
PLAN
To collect data/information on 12 - 14 CF patients aged 6 - 1 4  yrs, between November 1995, 
and March 1997.
Each child will be followed/measured for one month - through his/her hospital stay, and 
‘recovery’ from the chest infection at home.
This will allow us to identify any changes which may occur in;
(I) the amount of food eaten by the child
(ii) the amount of energy/calories they use/bum up, and
(iii) their body weight
HOW?
It will involve your child taking part in a series of simple measurements, which will be carried 
out by the investigator; Part I - in hospital, and Part II - at home.
Two of those measurements will require the co-operation/participation of your child and 
yourself. These are;
- 3 day Diet diary
- in hospital, and then at home every 2 days.
- 3 day stool collection
- in hospital, and once again, for 3 days at home.
For both of these, there will be full guidance, and support.
In order to carry out Part 2, regular home visits, and telephone calls will be essential to gather 
all the information, and to ensure all collections & recordings go smoothly. This will be 
arranged after discussion with those concerned.
A ‘Measurement Plan’ / Schedule will be put together for you to refer to.
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APPENDIX 5.4.
Acceptable Household Measures Guidelines
Described below is a list of acceptable household measures that were used throughout the 
dietary record period, for each subject in the study.
A GUIDE TO "HANDY MEASURES"
Describe the portions in household measures.
Acceptable measurements include:
(i) SPOONFULS: Tablespoons, Dessertspoons, Teaspoons.
Please state whether flat/heaped/rounded, and the number.
eg. cereals, sugar, sauces, jams and powdered drinks such 
as Ovaltine, Horlicks.
(ii) SLICES Give indication of thickness of slice, and how many.
(iii) LIQUIDS Can be measured in teacups, or tablespoons, or measured
in a measuring jug.
(iv) BUTTER, MARGARINE & SPREADS:
Indicate how thickly they are spread. State which brand 
used.
(v) RICE & PASTA (COOKED):
Record in tablespoons, or number of strands (for spaghetti).
(vi) READY TO EAT MEALS:
State the make or brand, and weight given on packet - then 
how much of the meal eaten.
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APPENDIX 5.5.
Faecal Fats - Measurement Protocol
The following standard method was used to determine the lipid content of each batch of 2 - 3 
day stool samples collected, for both exacerbation and clinically infection free phases, where 
appropriate.
Source: Van der Kamer, J.H., Huinink, H.T., and Wayers, A.A. (1949). J. Biol. Chem. 177; 
347. (modified).
Reagents:
1 Stock potassium hydroxide KOH 60g/100ml in water.
2 Alcoholic potassium hydroxide 5 g/100ml
- 25ml stock KOH to 300ml absolute alcohol (96%, Pharmacy Dept), including 1ml 
amyl alcohol.
3 Standard alcoholic sodium hydroxide (for titration) 0. IN.
- 4.00g NaOH dissolved in 100ml water and made up to 1 litre with absolute 
alcohol. Allow to stand overnight. Standardize against 0. IN oxalic acid (accurate) 
using phenolphthalein as indicator.
4 Oxalic acid 0. IN.
- 6.301g (C00H)2. ^H20 to 1 litre with distilled water.
5 Thymol blue indicator.
- O.lg thymol blue dissolved in a little water and made up to 100ml with absolute 
alcohol.
6 Hydrochloric acid, 33% v/v.
- 330ml conc. HCl to 1 litre with distilled water.
7 Petrolium ether 40° - 60° B.P.
Method:
1 The complete collection of faeces is made up to a known volume (500ml, litre, etc) 
with water and emulsified for 2 - 3 minutes in an electric homoginiser.
2 A 25ml aliquot of the fluid lying beneath the froth is transferred to a 250ml pyrex 
glass conical flask (with rubber stopper). Add 95ml alcoholic KOH. Boil for 20 
minutes on a sand bath.
3 Cool the flask, add 30ml 33% (v/v) HCl, cool the flask, add 50ml petrolium ether 
(40° - 60°) and shake for a minute.
4 Allow contents of flask to settle and petrolium ether layer (top) to separate. Remove 10ml 
petrolium ether extract to a small conical flask. Add 1ml absolute alcohol containing 0.4% 
(v/v) amyl alcohol. Titrate against O.IN alcoholic sodium hydroxide with thymol blue as 
indicator.
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Calculation:
Grams.
Faecal fat = (Titration x Normality x 5 x Total volume x 284) / 25 x 100 
(fatty acids) (Volume NaOH Emulsion )
mmol.
Faecal fat = (Titration x Normality x 5 Total volume) / 25
(as stearic acid) (Volume NaOH Emulsion )
Express results per period of collection (e.g. 3 days), and per 24h.
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APPENDIX 5.6.
Dose Preparation For Doubly Labelled Water
The standard protocols described below were followed during both dose preparation, and dose 
administration for each subject in the study.
a Current dose used is 0.06ml/kg ^H20 and 1.6ml/kg H2 (10% enriched; 
normalised).
Doses made up on an individual basis per kg body weight for each child.
b Deliver approximate volume (nearest calculated ml) of each isotope into one medical 
flat via a micropore/acrodisc filter.
c Shake bottle well to mix the isotopes.
d Label bottle - subject name/code/date.
e Tighten bottle lid, then loosen slightly to break the seal - secure the lid with autoclave 
tape.
f Sterilse in the autoclave for a one hour cycle,
g Remove bottle, allow to cool - tighten bottle lid.
h Allow bottle to return to room temperature - shake bottle well to mix the dose. Add
flavouring if required - shake bottle well to mix the dose. Pipette 2 x 1.5ml aliquots
of dose into bijou pot - label bijou pots/subject code and freeze samples.
i Place dose/bottle in large resealable bag with 2 x flexible straws ~ label plastic bag
with subject name/code/ & date.
j Weigh plastic bag/bottle/dose/ & straws - record the weight in the dose book.
k Provide subject with dose - see subject dosing sheet.
1 Reweigh plastic bag/bottle/dose/ & straws - calculate mass of isotope consumed. 
*RECORD ALL SUBJECT DETAILS/CODES/WEIGHTS IN LAB DOSE BOOK*
SUBJECT DOSING PROCEDURE
a Ensure collection of baseline urine sample.
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b Make up dose - see dose preparation sheet,
c Weigh bottle/dose/straw/ & bag.
d Ask subject to ingest the whole dose using the straw provided.
e Abandon the procedure if any amount of the dose is spilled.
f  Once all the dose is ingested place straw and bottle back in the bag and reseal.
Reweigh to determine the dose consumed.
g Urine samples
Provide the subject with 3 x Universals with printed labels and their subject code in 
a large resealable bag.
Subject should collect 3 x 'spot' urine samples (at least 10ml, but do not overfill the 
Universal) at the following times:
i 24 hours/ one day after the dose.
ii 1 week after the dose.
iii 2 weeks after the dose.
It is essential that the subjects record the time of the sample collection on the 
Universal; that the urines have not been contaminated in any way by extraneous 
water during the collection; that the urines are stored appropriately (i.e. frozen 
if not being collected by the investigator).
Urine samples should not be collected first thing in the morning, but all other times 
are acceptable.
During DLW study subjects should be contacted to ensure the samples are being 
collected, stored, and labelled as necessary.
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APPENDIX 5.7.
Total Energy Expenditure (TEE) Calculation Steps
Presented below is a detailed description of the calculation steps for the determination of each 
subjects TEE, during both exacerbation and clinically infection free phases.
STEP 1 Back extrapolate to determine and enrichments when time = 0 
This step was equivalent to determining isotope enrichment if there had 
been instantaneous equilibration.
STEP 2 Calculate the point of interception using the following equation:
y = mx + c for
STEP 3 Calculate the dilution spaces (Vo & Vh) using the following equation:
Dilution Space = (TA / a) x (Ea - Et / Es - Ep)
T = amount of tap water used to dilute the dose (g).
A = dose given (g)
a = amount of dose used to make up the dilute dose (g)
Ea = enrichment of dilute dose (ppm)
Et = enrichment of tap water (ppm)
Ep = enrichment of pre-dose (ppm) - background enrichment 
Es = enrichment of body water when t = 0 (ppm)
(IDECG 1990)
NB It was necessary in some cases to adjust the dilution spaces to a physiological value : 
1.05. Deuterium (%%) dilution space is always greater than *^0. dilution space is 
approximately the same as body water, with %  being typically 4% greater than the subjects 
own body water (IDECG 1990). Coward, Ritz & Cole (1994) stated that the ratio of dilution
spaces should be between 1.03 - 1.04, but noted that this is often not the case. Schoeller et al
(1986) suggested that any difference in observed dilution space ratio is probably due to a 
technical error then the ratio must be adjusted to the more physiological value of 1.04 - 1.05. 
Coward et al (1994) did concede that specific groups have different ratios (possibly due to 
altered body composition), and that this average ratio of 1.04 - 1.05 may not apply in all cases. 
In this study of children with CF the observed ratios tended to be slightly higher than those 
quoted in the literature, and it is thought that the differences were technical (sample preparation 
for mass spectrometry), rather than biological in origin. Thus the dilution spaces were adjusted 
to make them more physiological (Coward et al 1994). The deuterium space (^ H^ ) was 
adjusted to give the dilution space ratio 1.05 where necessary.
STEP 4 Calculate the rate constants (Ko & Kh)
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K = (Incl - lnc2) /  t
STEP 5 The mean daily C0 2  production (rC02 1/day), was calculated according to
the equation (A6) proposed by Schoeller et al (1986) in his human validation 
study. This equation assumed isotopic fractionation of breath water only, and 
rather than employ TBW for the pool size the isotope dilution spaces were used. 
A further assumption made, was that and ^ H2 had been estimated as being 1%
and 4% larger, respectively than total body water (TBW) itself (Johnson &
Halliday 1993).
rC0 2  = (N / 2.078) x (1.01K„ - 1.04 Kh) - 0.0246 rGF 
moles/d
where rGF = 1.05 N (K« - Kh)
where N = the average dilution space (moles)
NB : conversion to 1/d from moles Co 2/d 
(IgCOz = 510.2 ml CO2)
STEP 6 (i) Calculation of the correct energy equivalent per litre CO2 produced, from 
dietary composition data.
Mean % Energy from protein 
% Energy from fat 
% Energy from Cho
(change each to a proportion of it's % energy value).
(ii) Calculate the energy equivalents for
Protein 5.56 kcal/1 x
Fat 6.70kcal/l x above value.
Cho 5.00kcal/l x
ADD to get total kcal/1 & convert to kJ/1.
(Schmidt-Nielsen 1980).
(iii) Calculate TEE (kJ/kg per day), by multiplying the answer obtained from
Step 5 (rCOi).
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APPENDIX 5,8.
Body Composition Measurement - Bioelectrical Impedance Technique
Body composition, estimated by the tetrapolar whole body impedance (BIA) method, was 
carried out in each subject in accordance with the measurement techniques given below.
1 The subject was requested to lie flat, having removed the right shoe and sock.
2 Care was taken to ensure that no parts of the body were touching one another.
3 Self adhesive disposable electrodes were attatched to the right hand, and right foot.
4 The two main leads of the Bodystat were attached as follows:
Right hand: Red lead
Black lead 
Right foot: Red lead
Black lead
Behind knuckle of middle finger.
On wrist next to prominent ulnar bone.
Behind second toe, next to big toe.
On ankle, level with, and between medial and lateral 
malleoli.
(Large protruding bones on the side of the ankle).
5 The unit was switched to the ON position.
6 The enter key pressed. The screen then displayed the measurement on the LCD screen after 
3 -4  seconds.
The resistance figure (Ohms) displayed was subsequently entered into the Houtkooper et al 
equation (1992), which was used to predict FFM, FM and % body fat, in all subjects.
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APPENDIX 5.9.
Body Composition Measurement - Skinfold Thickness Techniques
Described below are the standard skinfold measurement techniques employed throughout the 
study.
Triceps Skinfold
The reference point for this measurement is the midpoint of the distance between the tip of the 
acromion process (scapulae), to the olecranon process of the ulna. This was measured with the 
arm bent at right-angles (90°), and then the reference point marked. The skinfold was then 
measured 1cm above the marked level, with arms hanging loosely by the sides, on the posterior 
aspect of the arm (Weiner & Lourie 1969).
Biceps Skinfold
This skinfold was measured 1 cm above the marked line for the triceps measurement, at the 
front of the arm above the centre of the antecubital fossa (Weiner & Lourie 1969).
Subscapular Skinfold
The reference measurement was made 1 inch, just below the angle of the scapula, diagonally, 
and approximately 45” to the subjects spine, along the natural cleavage lines of the skin 
(Lohman et al 1988).
Suprailliac Skinfold
The point of measurement for this skinfold occured 2cm directly above the illiac crest (Lohman 
et al 1988).
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APPENDIX 5.10.
Clinical Assessement of Symptoms During Acute Exacerbation
Presented below are the radiological results for each subject, corresponding to the time of acute 
exacerbation, (to be read in conjunction with Sections.2.0 Table 2).
Radiology Comments
Subject Name 
1
Comments
"... appearances consistent with intercurrent 
infection...”
".. .the appearances suggest intercurrent 
infection...”
“ appearances in right upper lobe are 
worse than on previous film ,and they 
suggest superimposed infection “
4 No X-ray. Sputum sample showed 
Pseudomonas. Admitted for antibiotic 
therapy.
“ increased mottled opacification & 
bronchial wall thickening of both bases, 
consistent with exacerbation.”
“ the lungs show no focal active infection'
147
7 “ deterioration in appearance “
“ patchy changes are also evident in left 
lower lobe “
g “ no radiological features of active
infection” “ chronic infection in 
sinuses"
10 No radiology details available.
12 " more confluent shadowing in right upper
zone compared with 16.6.96 film. 
Appearances suggest changes in left upper 
lobe “
13  “ Allowing for technical differences, there
is no radiological change and no features of 
active infection “
14  " lung fields show peribronchial thickening
“ “ no evidence of consolidative change ”
15  x-ray : 25.2.97
" no interval deterioration, & no evidence 
of active infection "
15 " n o  significant change in typical changes
of CF. No definite areas of focal 
consolidation demonstrated”
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